{ "version": "2.2", "instance": { "gsk-20260617.htm": { "nsprefix": "gsk", "nsuri": "http://gsk.com/20260617", "dts": { "inline": { "local": [ "gsk-20260617.htm" ] }, "schema": { "local": [ "gsk-20260617.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/2023/calculation-1.1.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd", "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd", "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd", "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd", "https://xbrl.fasb.org/us-gaap/2025/ebp/elts/us-gaap-ebp-2025.xsd", "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd", "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd", "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd", "https://xbrl.sec.gov/country/2025/country-2025.xsd", "https://xbrl.sec.gov/dei/2025/dei-2025.xsd", "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd" ] }, "calculationLink": { "local": [ "gsk-20260617_cal.xml" ] }, "definitionLink": { "local": [ "gsk-20260617_def.xml" ] }, "labelLink": { "local": [ "gsk-20260617_lab.xml" ] }, "presentationLink": { "local": [ "gsk-20260617_pre.xml" ] } }, "keyStandard": 73, "keyCustom": 26, "axisStandard": 7, "axisCustom": 0, "memberStandard": 16, "memberCustom": 10, "hidden": { "total": 6, "http://gsk.com/20260617": 2, "http://xbrl.sec.gov/dei/2025": 4 }, "contextCount": 213, "entityCount": 1, "segmentCount": 26, "elementCount": 184, "unitCount": 8, "baseTaxonomies": { "http://fasb.org/us-gaap-ebp/2025": 314, "http://xbrl.sec.gov/dei/2025": 9 }, "report": { "R1": { "role": "http://gsk.com/role/Cover", "longName": "0000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "first": true, "unique": true } }, "R2": { "role": "http://gsk.com/role/StatementsofNetAssetsAvailableforBenefits", "longName": "0000002 - Statement - Statements of Net Assets Available for Benefits", "shortName": "Statements of Net Assets Available for Benefits", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValueAndNavTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustContractValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "unique": true } }, "R3": { "role": "http://gsk.com/role/StatementofChangesinNetAssetsAvailableforBenefits", "longName": "0000003 - Statement - Statement of Changes in Net Assets Available for Benefits", "shortName": "Statement of Changes in Net Assets Available for Benefits", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForInterestIncomeOnInvestment", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForInterestIncomeOnInvestment", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "first": true, "unique": true } }, "R4": { "role": "http://gsk.com/role/DescriptionofthePlan", "longName": "0000004 - Disclosure - Description of the Plan", "shortName": "Description of the Plan", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "4", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap-ebp:EmployeeBenefitPlanDescriptionOfPlanTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap-ebp:EmployeeBenefitPlanDescriptionOfPlanTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "first": true, "unique": true } }, "R5": { "role": "http://gsk.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncements", "longName": "0000005 - Disclosure - Summary of Significant Accounting Policies and Recent Accounting Pronouncements", "shortName": "Summary of Significant Accounting Policies and Recent Accounting Pronouncements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "5", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap-ebp:EmployeeBenefitPlanSummaryOfAccountingPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap-ebp:EmployeeBenefitPlanSummaryOfAccountingPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "first": true, "unique": true } }, "R6": { "role": "http://gsk.com/role/SyntheticGuaranteedInvestmentContracts", "longName": "0000006 - Disclosure - Synthetic Guaranteed Investment Contracts", "shortName": "Synthetic Guaranteed Investment Contracts", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "6", "firstAnchor": { "contextRef": "c-2", "name": "gsk:SyntheticGuaranteedInvestmentContractsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "gsk:SyntheticGuaranteedInvestmentContractsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "first": true, "unique": true } }, "R7": { "role": "http://gsk.com/role/FairValueMeasurements", "longName": "0000007 - Disclosure - Fair Value Measurements", "shortName": "Fair Value Measurements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "7", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValueAndNavTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValueAndNavTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "first": true, "unique": true } }, "R8": { "role": "http://gsk.com/role/RelatedPartyandPartyinInterestTransactions", "longName": "0000008 - Disclosure - Related Party and Party in Interest Transactions", "shortName": "Related Party and Party in Interest Transactions", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap-ebp:EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap-ebp:EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "first": true, "unique": true } }, "R9": { "role": "http://gsk.com/role/PlanTermination", "longName": "0000009 - Disclosure - Plan Termination", "shortName": "Plan Termination", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap-ebp:EmployeeBenefitPlanPlanTerminationTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap-ebp:EmployeeBenefitPlanPlanTerminationTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "first": true, "unique": true } }, "R10": { "role": "http://gsk.com/role/TaxStatus", "longName": "0000010 - Disclosure - Tax Status", "shortName": "Tax Status", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap-ebp:EmployeeBenefitPlanTaxStatusTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap-ebp:EmployeeBenefitPlanTaxStatusTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "first": true, "unique": true } }, "R11": { "role": "http://gsk.com/role/ReconciliationtoForm5500", "longName": "0000011 - Disclosure - Reconciliation to Form 5500", "shortName": "Reconciliation to Form 5500", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap-ebp:EmployeeBenefitPlanReconciliationToForm5500TextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap-ebp:EmployeeBenefitPlanReconciliationToForm5500TextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "first": true, "unique": true } }, "R12": { "role": "http://gsk.com/role/RisksandUncertainties", "longName": "0000012 - Disclosure - Risks and Uncertainties", "shortName": "Risks and Uncertainties", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap-ebp:EmployeeBenefitPlanRiskAndUncertaintyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap-ebp:EmployeeBenefitPlanRiskAndUncertaintyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "first": true, "unique": true } }, "R13": { "role": "http://gsk.com/role/SubsequentEvents", "longName": "0000013 - Disclosure - Subsequent Events", "shortName": "Subsequent Events", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap-ebp:EmployeeBenefitPlanSubsequentEventTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap-ebp:EmployeeBenefitPlanSubsequentEventTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "first": true, "unique": true } }, "R14": { "role": "http://gsk.com/role/ScheduleHLine4iScheduleofAssetsHeldatEndofYear", "longName": "0000014 - Disclosure - Schedule H, Line 4i - Schedule of Assets (Held at End of Year)", "shortName": "Schedule H, Line 4i - Schedule of Assets (Held at End of Year)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap-ebp:EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap-ebp:EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "first": true, "unique": true } }, "R15": { "role": "http://gsk.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsPolicies", "longName": "0000015 - Disclosure - Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Policies)", "shortName": "Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "15", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap-ebp:EmployeeBenefitPlanBasisOfAccountingPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap-ebp:EmployeeBenefitPlanBasisOfAccountingPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "first": true, "unique": true } }, "R16": { "role": "http://gsk.com/role/FairValueMeasurementsTables", "longName": "0000016 - Disclosure - Fair Value Measurements (Tables)", "shortName": "Fair Value Measurements (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "16", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValueAndNavTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValueAndNavTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "first": true, "unique": true } }, "R17": { "role": "http://gsk.com/role/ReconciliationtoForm5500Tables", "longName": "0000017 - Disclosure - Reconciliation to Form 5500 (Tables)", "shortName": "Reconciliation to Form 5500 (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "17", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap-ebp:EmployeeBenefitPlanReconciliationToForm5500TableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap-ebp:EmployeeBenefitPlanReconciliationToForm5500TableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "first": true, "unique": true } }, "R18": { "role": "http://gsk.com/role/RisksandUncertaintiesTables", "longName": "0000018 - Disclosure - Risks and Uncertainties (Tables)", "shortName": "Risks and Uncertainties (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "18", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap-ebp:EbpRiskAndUncertaintyTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap-ebp:EbpRiskAndUncertaintyTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "first": true, "unique": true } }, "R19": { "role": "http://gsk.com/role/DescriptionofthePlanDetails", "longName": "0000019 - Disclosure - Description of the Plan (Details)", "shortName": "Description of the Plan (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "19", "firstAnchor": { "contextRef": "c-2", "name": "gsk:EBPEmployerContributionNumberOfHoursOfCreditedService", "unitRef": "servicehours", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "gsk:EBPEmployerContributionNumberOfHoursOfCreditedService", "unitRef": "servicehours", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "first": true, "unique": true } }, "R20": { "role": "http://gsk.com/role/SyntheticGuaranteedInvestmentContractsDetails", "longName": "0000020 - Disclosure - Synthetic Guaranteed Investment Contracts (Details)", "shortName": "Synthetic Guaranteed Investment Contracts (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "20", "firstAnchor": { "contextRef": "c-3", "name": "gsk:EBPSyntheticGuaranteedInvestmentContractsPercentageOfUnderlyingAssetsOwnedByThePlan", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "gsk:EBPSyntheticGuaranteedInvestmentContractsPercentageOfUnderlyingAssetsOwnedByThePlan", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "first": true, "unique": true } }, "R21": { "role": "http://gsk.com/role/FairValueMeasurementsFairvaluehierarchyDetails", "longName": "0000021 - Disclosure - Fair Value Measurements - Fair value hierarchy (Details)", "shortName": "Fair Value Measurements - Fair value hierarchy (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "21", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValueAndNavTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-25", "name": "us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValueAndNavTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "unique": true } }, "R22": { "role": "http://gsk.com/role/FairValueMeasurementsInvestmentsmeasuredatfairvaluebasedonNAVDetails", "longName": "0000022 - Disclosure - Fair Value Measurements - Investments measured at fair value based on NAV (Details)", "shortName": "Fair Value Measurements - Investments measured at fair value based on NAV (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "22", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValueAndNavTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-45", "name": "us-gaap-ebp:EbpFairValueInvestmentNavRedemptionNoticePeriod", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "unique": true } }, "R23": { "role": "http://gsk.com/role/RelatedPartyandPartyinInterestTransactionsDetails", "longName": "0000023 - Disclosure - Related Party and Party in Interest Transactions (Details)", "shortName": "Related Party and Party in Interest Transactions (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "23", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForDividendIncomeOnInvestment", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-68", "name": "gsk:EBPInvestmentManagementServicesFeesPaid", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "unique": true } }, "R24": { "role": "http://gsk.com/role/ReconciliationtoForm5500ReconciliationofNetAssetsAvailableforBenefitDetails", "longName": "0000024 - Disclosure - Reconciliation to Form 5500 - Reconciliation of Net Assets Available for Benefit (Details)", "shortName": "Reconciliation to Form 5500 - Reconciliation of Net Assets Available for Benefit (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "24", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap-ebp:EmployeeBenefitPlanNetAssetAvailableForBenefit", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap-ebp:EmployeeBenefitPlanReconciliationToForm5500TableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap-ebp:EmployeeBenefitPlanReconciliationToForm5500NetAssetAvailableForBenefitAllocationToWithdrawingParticipantNotYetPaid", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap-ebp:EmployeeBenefitPlanReconciliationToForm5500TableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "unique": true } }, "R25": { "role": "http://gsk.com/role/ReconciliationtoForm5500ReconciliationofNetIncomeDetails", "longName": "0000025 - Disclosure - Reconciliation to Form 5500 - Reconciliation of Net Income (Details)", "shortName": "Reconciliation to Form 5500 - Reconciliation of Net Income (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "25", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecrease", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap-ebp:EmployeeBenefitPlanReconciliationToForm5500TableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap-ebp:EmployeeBenefitPlanReconciliationToForm5500ChangeInNetAssetAvailableForBenefitDecreaseForDeemedDistributionCurrentPeriod", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap-ebp:EmployeeBenefitPlanReconciliationToForm5500TableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "unique": true } }, "R26": { "role": "http://gsk.com/role/ReconciliationtoForm5500ReconciliationofBenefitPaidDetails", "longName": "0000026 - Disclosure - Reconciliation to Form 5500 - Reconciliation of Benefit Paid (Details)", "shortName": "Reconciliation to Form 5500 - Reconciliation of Benefit Paid (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "26", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForPaymentToParticipant", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap-ebp:EmployeeBenefitPlanForm5500CaptionPaymentToParticipant", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "unique": true } }, "R27": { "role": "http://gsk.com/role/RisksandUncertaintiesNarrativeDetails", "longName": "0000027 - Disclosure - Risks and Uncertainties - Narrative (Details)", "shortName": "Risks and Uncertainties - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "27", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap-ebp:EbpRiskAndUncertaintyConcentrationOfInvestmentBenchmarkThresholdPercentage", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "div", "us-gaap-ebp:EbpRiskAndUncertaintyTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-70", "name": "us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "unique": true } }, "R28": { "role": "http://gsk.com/role/RisksandUncertaintiesScheduleofinvestmentsDetails", "longName": "0000028 - Disclosure - Risks and Uncertainties - Schedule of investments (Details)", "shortName": "Risks and Uncertainties - Schedule of investments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "28", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap-ebp:EbpRiskAndUncertaintyConcentrationOfInvestmentBenchmarkThresholdPercentage", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "div", "us-gaap-ebp:EbpRiskAndUncertaintyTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-73", "name": "us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap-ebp:EbpRiskAndUncertaintyTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "unique": true } }, "R29": { "role": "http://gsk.com/role/SubsequentEventsDetails", "longName": "0000029 - Disclosure - Subsequent Events (Details)", "shortName": "Subsequent Events (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "29", "firstAnchor": { "contextRef": "c-80", "name": "gsk:EBPBusinessCombinationNumberOfEmployeesTerminated", "unitRef": "employee", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-80", "name": "gsk:EBPBusinessCombinationNumberOfEmployeesTerminated", "unitRef": "employee", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "first": true, "unique": true } }, "R30": { "role": "http://gsk.com/role/ScheduleHLine4iScheduleofAssetsHeldatEndofYearDetails", "longName": "0000030 - Disclosure - Schedule H, Line 4i - Schedule of Assets (Held at End of Year) (Details)", "shortName": "Schedule H, Line 4i - Schedule of Assets (Held at End of Year) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "30", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap-ebp:EmployeeBenefitPlanPlanNumber", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "us-gaap-ebp:EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap-ebp:EmployeeBenefitPlanPlanNumber", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "us-gaap-ebp:EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "gsk-20260617.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AmendmentFlag", "presentation": [ "http://gsk.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "gsk_BlackRockGovernmentShortTermInvestmentFundMember": { "xbrltype": "domainItemType", "nsuri": "http://gsk.com/20260617", "localname": "BlackRockGovernmentShortTermInvestmentFundMember", "presentation": [ "http://gsk.com/role/FairValueMeasurementsInvestmentsmeasuredatfairvaluebasedonNAVDetails" ], "lang": { "en-us": { "role": { "terseLabel": "BlackRock Government Short Term Investment Fund", "label": "BlackRock Government Short Term Investment Fund [Member]", "documentation": "BlackRock Government Short Term Investment Fund" } } }, "auth_ref": [] }, "gsk_BlackRockRussell2500AlphaTiltsFundFMember": { "xbrltype": "domainItemType", "nsuri": "http://gsk.com/20260617", "localname": "BlackRockRussell2500AlphaTiltsFundFMember", "presentation": [ "http://gsk.com/role/FairValueMeasurementsInvestmentsmeasuredatfairvaluebasedonNAVDetails" ], "lang": { "en-us": { "role": { "terseLabel": "BlackRock Russell 2500 Alpha Tilts \u2013 Fund F", "label": "BlackRock Russell 2500 Alpha Tilts \u2013 Fund F [Member]", "documentation": "BlackRock Russell 2500 Alpha Tilts \u2013 Fund F" } } }, "auth_ref": [] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommonStockMember", "presentation": [ "http://gsk.com/role/FairValueMeasurementsFairvaluehierarchyDetails", "http://gsk.com/role/ScheduleHLine4iScheduleofAssetsHeldatEndofYearDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock", "label": "Common Stock [Member]" } } }, "auth_ref": [ "r155" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DefinedBenefitPlanCommonCollectiveTrustMember", "presentation": [ "http://gsk.com/role/ScheduleHLine4iScheduleofAssetsHeldatEndofYearDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common collective trust", "label": "Common Collective Trust [Member]" } } }, "auth_ref": [ "r121", "r130", "r135", "r142" ] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentInformationLineItems", "presentation": [ "http://gsk.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Information [Line Items]", "label": "Document Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentInformationTable", "presentation": [ "http://gsk.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Information [Table]", "label": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentType", "presentation": [ "http://gsk.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "gsk_EBP002Member": { "xbrltype": "domainItemType", "nsuri": "http://gsk.com/20260617", "localname": "EBP002Member", "presentation": [ "http://gsk.com/role/Cover", "http://gsk.com/role/DescriptionofthePlan", "http://gsk.com/role/DescriptionofthePlanDetails", "http://gsk.com/role/FairValueMeasurements", "http://gsk.com/role/FairValueMeasurementsFairvaluehierarchyDetails", "http://gsk.com/role/FairValueMeasurementsInvestmentsmeasuredatfairvaluebasedonNAVDetails", "http://gsk.com/role/FairValueMeasurementsTables", "http://gsk.com/role/PlanTermination", "http://gsk.com/role/ReconciliationtoForm5500", "http://gsk.com/role/ReconciliationtoForm5500ReconciliationofBenefitPaidDetails", "http://gsk.com/role/ReconciliationtoForm5500ReconciliationofNetAssetsAvailableforBenefitDetails", "http://gsk.com/role/ReconciliationtoForm5500ReconciliationofNetIncomeDetails", "http://gsk.com/role/ReconciliationtoForm5500Tables", "http://gsk.com/role/RelatedPartyandPartyinInterestTransactions", "http://gsk.com/role/RelatedPartyandPartyinInterestTransactionsDetails", "http://gsk.com/role/RisksandUncertainties", "http://gsk.com/role/RisksandUncertaintiesNarrativeDetails", "http://gsk.com/role/RisksandUncertaintiesScheduleofinvestmentsDetails", "http://gsk.com/role/RisksandUncertaintiesTables", "http://gsk.com/role/ScheduleHLine4iScheduleofAssetsHeldatEndofYear", "http://gsk.com/role/ScheduleHLine4iScheduleofAssetsHeldatEndofYearDetails", "http://gsk.com/role/StatementofChangesinNetAssetsAvailableforBenefits", "http://gsk.com/role/StatementsofNetAssetsAvailableforBenefits", "http://gsk.com/role/SubsequentEvents", "http://gsk.com/role/SubsequentEventsDetails", "http://gsk.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncements", "http://gsk.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsPolicies", "http://gsk.com/role/SyntheticGuaranteedInvestmentContracts", "http://gsk.com/role/SyntheticGuaranteedInvestmentContractsDetails", "http://gsk.com/role/TaxStatus" ], "lang": { "en-us": { "role": { "terseLabel": "EBP 002", "label": "EBP 002 [Member]", "documentation": "EBP 002" } } }, "auth_ref": [] }, "gsk_EBPAdministrativeExpensePaid": { "xbrltype": "monetaryItemType", "nsuri": "http://gsk.com/20260617", "localname": "EBPAdministrativeExpensePaid", "crdr": "credit", "presentation": [ "http://gsk.com/role/DescriptionofthePlanDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Administrative expense paid", "label": "EBP, Administrative Expense Paid", "documentation": "EBP, Administrative Expense Paid" } } }, "auth_ref": [] }, "gsk_EBPBenefitsProcessingPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://gsk.com/20260617", "localname": "EBPBenefitsProcessingPaid", "crdr": "credit", "presentation": [ "http://gsk.com/role/DescriptionofthePlanDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Benefits processing paid", "label": "EBP, Benefits Processing Paid", "documentation": "EBP, Benefits Processing Paid" } } }, "auth_ref": [] }, "gsk_EBPBusinessCombinationNumberOfEmployeesTerminated": { "xbrltype": "integerItemType", "nsuri": "http://gsk.com/20260617", "localname": "EBPBusinessCombinationNumberOfEmployeesTerminated", "presentation": [ "http://gsk.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of employees terminated", "label": "EBP, Business Combination, Number of Employees Terminated", "documentation": "EBP, Business Combination, Number of Employees Terminated" } } }, "auth_ref": [] }, "gsk_EBPCustodyFeesPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://gsk.com/20260617", "localname": "EBPCustodyFeesPaid", "crdr": "credit", "presentation": [ "http://gsk.com/role/DescriptionofthePlanDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Custody fees paid", "label": "EBP, Custody Fees Paid", "documentation": "EBP, Custody Fees Paid" } } }, "auth_ref": [] }, "gsk_EBPDefaultInvestmentTargetRetirementAge": { "xbrltype": "integerItemType", "nsuri": "http://gsk.com/20260617", "localname": "EBPDefaultInvestmentTargetRetirementAge", "presentation": [ "http://gsk.com/role/DescriptionofthePlanDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Default investment, target retirement age", "label": "EBP, Default Investment, Target Retirement Age", "documentation": "EBP, Default Investment, Target Retirement Age" } } }, "auth_ref": [] }, "gsk_EBPEmployeeContributionCatchUpContributionsEligibilityAge": { "xbrltype": "integerItemType", "nsuri": "http://gsk.com/20260617", "localname": "EBPEmployeeContributionCatchUpContributionsEligibilityAge", "presentation": [ "http://gsk.com/role/DescriptionofthePlanDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Catch-up contributions eligibility, age", "label": "EBP, Employee Contribution, Catch-Up Contributions Eligibility, Age", "documentation": "EBP, Employee Contribution, Catch-Up Contributions Eligibility, Age" } } }, "auth_ref": [] }, "gsk_EBPEmployerADRsMember": { "xbrltype": "domainItemType", "nsuri": "http://gsk.com/20260617", "localname": "EBPEmployerADRsMember", "presentation": [ "http://gsk.com/role/RelatedPartyandPartyinInterestTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "GSK ADRs", "label": "EBP, Employer, ADRs [Member]", "documentation": "EBP, Employer, ADRs" } } }, "auth_ref": [] }, "gsk_EBPEmployerContributionNumberOfHoursOfCreditedService": { "xbrltype": "integerItemType", "nsuri": "http://gsk.com/20260617", "localname": "EBPEmployerContributionNumberOfHoursOfCreditedService", "presentation": [ "http://gsk.com/role/DescriptionofthePlanDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of hours of credited service", "label": "EBP, Employer Contribution, Number Of Hours Of Credited Service", "documentation": "EBP, Employer Contribution, Number Of Hours Of Credited Service" } } }, "auth_ref": [] }, "gsk_EBPEmployerCoreContributionPercentage": { "xbrltype": "percentItemType", "nsuri": "http://gsk.com/20260617", "localname": "EBPEmployerCoreContributionPercentage", "presentation": [ "http://gsk.com/role/DescriptionofthePlanDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Employer core contribution, percentage", "label": "EBP, Employer Core Contribution, Percentage", "documentation": "EBP, Employer Core Contribution, Percentage" } } }, "auth_ref": [] }, "gsk_EBPFairValueInvestmentNAVRedemptionPercentageOfAssetsThreshold": { "xbrltype": "percentItemType", "nsuri": "http://gsk.com/20260617", "localname": "EBPFairValueInvestmentNAVRedemptionPercentageOfAssetsThreshold", "presentation": [ "http://gsk.com/role/FairValueMeasurementsInvestmentsmeasuredatfairvaluebasedonNAVDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of assets, threshold", "label": "EBP, Fair Value, Investment, NAV, Redemption, Percentage of Assets, Threshold", "documentation": "EBP, Fair Value, Investment, NAV, Redemption, Percentage of Assets, Threshold" } } }, "auth_ref": [] }, "gsk_EBPInvestmentManagementServicesFeesPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://gsk.com/20260617", "localname": "EBPInvestmentManagementServicesFeesPaid", "crdr": "credit", "presentation": [ "http://gsk.com/role/RelatedPartyandPartyinInterestTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investment management services fees paid", "label": "EBP, Investment Management Services Fees Paid", "documentation": "EBP, Investment Management Services Fees Paid" } } }, "auth_ref": [] }, "gsk_EBPMaximumNumberOfAnnualPartialDistributions": { "xbrltype": "integerItemType", "nsuri": "http://gsk.com/20260617", "localname": "EBPMaximumNumberOfAnnualPartialDistributions", "presentation": [ "http://gsk.com/role/DescriptionofthePlanDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum number of annual partial distributions", "label": "EBP, Maximum Number of Annual Partial Distributions", "documentation": "EBP, Maximum Number of Annual Partial Distributions" } } }, "auth_ref": [] }, "gsk_EBPMaximumPeriodOfAnnualDistributions": { "xbrltype": "durationItemType", "nsuri": "http://gsk.com/20260617", "localname": "EBPMaximumPeriodOfAnnualDistributions", "presentation": [ "http://gsk.com/role/DescriptionofthePlanDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum period of annual distributions", "label": "EBP, Maximum Period of Annual Distributions", "documentation": "EBP, Maximum Period of Annual Distributions" } } }, "auth_ref": [] }, "gsk_EBPNoteReceivableFromParticipantGeneralLoanMaximumBorrowingTerm": { "xbrltype": "durationItemType", "nsuri": "http://gsk.com/20260617", "localname": "EBPNoteReceivableFromParticipantGeneralLoanMaximumBorrowingTerm", "presentation": [ "http://gsk.com/role/DescriptionofthePlanDetails" ], "lang": { "en-us": { "role": { "terseLabel": "General loan, maximum borrowing term", "label": "EBP, Note Receivable From Participant, General Loan, Maximum Borrowing Term", "documentation": "EBP, Note Receivable From Participant, General Loan, Maximum Borrowing Term" } } }, "auth_ref": [] }, "gsk_EBPNoteReceivableFromParticipantGeneralLoanMinimumBorrowingTerm": { "xbrltype": "durationItemType", "nsuri": "http://gsk.com/20260617", "localname": "EBPNoteReceivableFromParticipantGeneralLoanMinimumBorrowingTerm", "presentation": [ "http://gsk.com/role/DescriptionofthePlanDetails" ], "lang": { "en-us": { "role": { "terseLabel": "General loan, minimum borrowing term", "label": "EBP, Note Receivable From Participant, General Loan, Minimum Borrowing Term", "documentation": "EBP, Note Receivable From Participant, General Loan, Minimum Borrowing Term" } } }, "auth_ref": [] }, "gsk_EBPNoteReceivableFromParticipantPrimaryResidenceLoanMaximumBorrowingTerm": { "xbrltype": "durationItemType", "nsuri": "http://gsk.com/20260617", "localname": "EBPNoteReceivableFromParticipantPrimaryResidenceLoanMaximumBorrowingTerm", "presentation": [ "http://gsk.com/role/DescriptionofthePlanDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Primary residence loan, maximum borrowing term", "label": "EBP, Note Receivable From Participant, Primary Residence Loan, Maximum Borrowing Term", "documentation": "EBP, Note Receivable From Participant, Primary Residence Loan, Maximum Borrowing Term" } } }, "auth_ref": [] }, "gsk_EBPNumberOfFunds": { "xbrltype": "integerItemType", "nsuri": "http://gsk.com/20260617", "localname": "EBPNumberOfFunds", "presentation": [ "http://gsk.com/role/FairValueMeasurementsInvestmentsmeasuredatfairvaluebasedonNAVDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of funds", "label": "EBP, Number Of Funds", "documentation": "EBP, Number Of Funds" } } }, "auth_ref": [] }, "gsk_EBPParticipantContributionPretaxAnnualCompensationToTotalCompensationPercentage": { "xbrltype": "percentItemType", "nsuri": "http://gsk.com/20260617", "localname": "EBPParticipantContributionPretaxAnnualCompensationToTotalCompensationPercentage", "presentation": [ "http://gsk.com/role/DescriptionofthePlanDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Annual compensation to total compensation, percentage", "label": "EBP, Participant Contribution, Pretax, Annual Compensation to Total Compensation, Percentage", "documentation": "EBP, Participant Contribution, Pretax, Annual Compensation to Total Compensation, Percentage" } } }, "auth_ref": [] }, "gsk_EBPParticipantLoanBasisSpreadOnVariableRate": { "xbrltype": "percentItemType", "nsuri": "http://gsk.com/20260617", "localname": "EBPParticipantLoanBasisSpreadOnVariableRate", "presentation": [ "http://gsk.com/role/DescriptionofthePlanDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Participant loan, basis spread on variable rate", "label": "EBP, Participant Loan, Basis Spread On Variable Rate", "documentation": "EBP, Participant Loan, Basis Spread On Variable Rate" } } }, "auth_ref": [] }, "gsk_EBPParticipantLoanProcessingFee": { "xbrltype": "monetaryItemType", "nsuri": "http://gsk.com/20260617", "localname": "EBPParticipantLoanProcessingFee", "crdr": "debit", "presentation": [ "http://gsk.com/role/DescriptionofthePlanDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Participant loan, processing fee", "label": "EBP, Participant Loan, Processing Fee", "documentation": "EBP, Participant Loan, Processing Fee" } } }, "auth_ref": [] }, "gsk_EBPPaymentOfBenefitsFirstThreshold": { "xbrltype": "monetaryItemType", "nsuri": "http://gsk.com/20260617", "localname": "EBPPaymentOfBenefitsFirstThreshold", "crdr": "credit", "presentation": [ "http://gsk.com/role/DescriptionofthePlanDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Payment of benefits, first threshold", "label": "EBP, Payment of Benefits, First Threshold", "documentation": "EBP, Payment of Benefits, First Threshold" } } }, "auth_ref": [] }, "gsk_EBPPaymentOfBenefitsSecondThreshold": { "xbrltype": "monetaryItemType", "nsuri": "http://gsk.com/20260617", "localname": "EBPPaymentOfBenefitsSecondThreshold", "crdr": "credit", "presentation": [ "http://gsk.com/role/DescriptionofthePlanDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Payment of benefits, second threshold", "label": "EBP, Payment of Benefits, Second Threshold", "documentation": "EBP, Payment of Benefits, Second Threshold" } } }, "auth_ref": [] }, "gsk_EBPPreTaxAndRothContributionsMinimumWithdrawingAge": { "xbrltype": "decimalItemType", "nsuri": "http://gsk.com/20260617", "localname": "EBPPreTaxAndRothContributionsMinimumWithdrawingAge", "presentation": [ "http://gsk.com/role/DescriptionofthePlanDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum withdrawing age for pre-tax and Roth contributions", "label": "EBP, Pre-Tax And Roth Contributions, Minimum Withdrawing Age", "documentation": "EBP, Pre-Tax And Roth Contributions, Minimum Withdrawing Age" } } }, "auth_ref": [] }, "gsk_EBPRequiredMinimumDistributionsMinimumAge": { "xbrltype": "integerItemType", "nsuri": "http://gsk.com/20260617", "localname": "EBPRequiredMinimumDistributionsMinimumAge", "presentation": [ "http://gsk.com/role/DescriptionofthePlanDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Required minimum distributions, minimum age", "label": "EBP, Required Minimum Distributions, Minimum Age", "documentation": "EBP, Required Minimum Distributions, Minimum Age" } } }, "auth_ref": [] }, "gsk_EBPSyntheticGuaranteedInvestmentContractsNumberOfSyntheticContractsIncludedInThePlan": { "xbrltype": "integerItemType", "nsuri": "http://gsk.com/20260617", "localname": "EBPSyntheticGuaranteedInvestmentContractsNumberOfSyntheticContractsIncludedInThePlan", "presentation": [ "http://gsk.com/role/SyntheticGuaranteedInvestmentContractsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of synthetic contracts included in the Plan", "label": "EBP, Synthetic Guaranteed Investment Contracts, Number of Synthetic Contracts Included in the Plan", "documentation": "EBP, Synthetic Guaranteed Investment Contracts, Number of Synthetic Contracts Included in the Plan" } } }, "auth_ref": [] }, "gsk_EBPSyntheticGuaranteedInvestmentContractsPercentageOfUnderlyingAssetsOwnedByThePlan": { "xbrltype": "percentItemType", "nsuri": "http://gsk.com/20260617", "localname": "EBPSyntheticGuaranteedInvestmentContractsPercentageOfUnderlyingAssetsOwnedByThePlan", "presentation": [ "http://gsk.com/role/SyntheticGuaranteedInvestmentContractsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of underlying assets owned by the Plan", "label": "EBP, Synthetic Guaranteed Investment Contracts, Percentage of Underlying Assets Owned by the Plan", "documentation": "EBP, Synthetic Guaranteed Investment Contracts, Percentage of Underlying Assets Owned by the Plan" } } }, "auth_ref": [] }, "us-gaap-ebp_EbpFairValueInvestmentNavRedemptionNoticePeriod": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EbpFairValueInvestmentNavRedemptionNoticePeriod", "presentation": [ "http://gsk.com/role/FairValueMeasurementsInvestmentsmeasuredatfairvaluebasedonNAVDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Redemption Notice Period", "label": "EBP, Fair Value, Investment, NAV, Redemption, Notice Period", "documentation": "Period for redemption notice required for investment held by employee stock purchase, saving, or similar plan (employee benefit plan (EBP)), that is measured at net asset value (NAV) per share as practical expedient for estimate of fair value, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r117", "r130" ] }, "us-gaap-ebp_EbpRiskAndUncertaintyConcentrationOfInvestmentAtFairValueToNetAssetsPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EbpRiskAndUncertaintyConcentrationOfInvestmentAtFairValueToNetAssetsPercentage", "presentation": [ "http://gsk.com/role/RisksandUncertaintiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "GSK investment, as percent of total investments", "label": "EBP, Risk and Uncertainty, Concentration of Investment at Fair Value to Net Assets, Percentage", "documentation": "Percentage of investment at fair value held by employee stock purchase, saving, or similar plan (employee benefit plan (EBP)), to net assets available for benefit representing concentration risk at or above applicable threshold." } } }, "auth_ref": [ "r185" ] }, "us-gaap-ebp_EbpRiskAndUncertaintyConcentrationOfInvestmentBenchmarkThresholdPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EbpRiskAndUncertaintyConcentrationOfInvestmentBenchmarkThresholdPercentage", "presentation": [ "http://gsk.com/role/RisksandUncertaintiesNarrativeDetails", "http://gsk.com/role/RisksandUncertaintiesScheduleofinvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Benchmark threshold percentage", "label": "EBP, Risk and Uncertainty, Concentration of Investment, Benchmark Threshold Percentage", "documentation": "Threshold percentage for investment applied to benchmark used for identifying concentration risk of employee stock purchase, saving, or similar plan (employee benefit plan (EBP))." } } }, "auth_ref": [ "r185" ] }, "us-gaap-ebp_EbpRiskAndUncertaintyLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EbpRiskAndUncertaintyLineItems", "presentation": [ "http://gsk.com/role/RisksandUncertaintiesNarrativeDetails", "http://gsk.com/role/RisksandUncertaintiesScheduleofinvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "EBP, Risk and Uncertainty [Line Items]", "label": "EBP, Risk and Uncertainty [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r185" ] }, "us-gaap-ebp_EbpRiskAndUncertaintyTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EbpRiskAndUncertaintyTable", "presentation": [ "http://gsk.com/role/RisksandUncertaintiesNarrativeDetails", "http://gsk.com/role/RisksandUncertaintiesScheduleofinvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "EBP, Risk and Uncertainty [Table]", "label": "EBP, Risk and Uncertainty [Table]", "documentation": "Disclosure of information about risk and uncertainty of employee stock purchase, saving, or similar plan (employee benefit plan (EBP)). Includes, but is not limited to, concentration risk." } } }, "auth_ref": [ "r185" ] }, "us-gaap-ebp_EbpRiskAndUncertaintyTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EbpRiskAndUncertaintyTableTextBlock", "presentation": [ "http://gsk.com/role/RisksandUncertaintiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "EBP, Risk and Uncertainty", "label": "EBP, Risk and Uncertainty [Table Text Block]", "documentation": "Tabular disclosure of risk and uncertainty of employee stock purchase, saving, or similar plan (employee benefit plan (EBP)). Includes, but is not limited to, concentration risk." } } }, "auth_ref": [ "r185" ] }, "us-gaap-ebp_EbpSubsequentEventAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EbpSubsequentEventAbstract", "lang": { "en-us": { "role": { "label": "EBP, Subsequent Event [Abstract]" } } }, "auth_ref": [] }, "us-gaap-ebp_EbpSubsequentEventLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EbpSubsequentEventLineItems", "presentation": [ "http://gsk.com/role/SubsequentEvents", "http://gsk.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "EBP, Subsequent Event [Line Items]", "label": "EBP, Subsequent Event [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r54", "r150" ] }, "us-gaap-ebp_EbpSubsequentEventTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EbpSubsequentEventTable", "presentation": [ "http://gsk.com/role/SubsequentEvents", "http://gsk.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "EBP, Subsequent Event [Table]", "label": "EBP, Subsequent Event [Table]", "documentation": "Disclosure of information about subsequent event for employee stock purchase, saving, or similar plan (employee benefit plan (EBP))." } } }, "auth_ref": [ "r54", "r150" ] }, "us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanAccountingPolicyAbstract", "lang": { "en-us": { "role": { "label": "EBP, Accounting Policy, Accounting Standard Update, and Change in Accounting Principle [Abstract]" } } }, "auth_ref": [] }, "us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanAccountingPolicyLineItems", "presentation": [ "http://gsk.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncements", "http://gsk.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "EBP, Accounting Policy [Line Items]", "label": "EBP, Accounting Policy [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r191", "r202" ] }, "us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanAccountingPolicyTable", "presentation": [ "http://gsk.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncements", "http://gsk.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "EBP, Accounting Policy [Table]", "label": "EBP, Accounting Policy [Table]", "documentation": "Disclosure of information about accounting policy for employee stock purchase, saving, or similar plan (employee benefit plan (EBP))." } } }, "auth_ref": [ "r191", "r202" ] }, "us-gaap-ebp_EmployeeBenefitPlanAccruedExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanAccruedExpense", "crdr": "credit", "calculation": { "http://gsk.com/role/StatementsofNetAssetsAvailableforBenefits": { "parentTag": "us-gaap-ebp_EmployeeBenefitPlanLiability", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://gsk.com/role/StatementsofNetAssetsAvailableforBenefits" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued investment management fees", "label": "EBP, Accrued Expense", "documentation": "Amount of liability for expense incurred but not yet paid by employee stock purchase, saving, or similar plan (employee benefit plan (EBP))." } } }, "auth_ref": [ "r113", "r145", "r146", "r147", "r187", "r201" ] }, "us-gaap-ebp_EmployeeBenefitPlanAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanAsset", "crdr": "debit", "calculation": { "http://gsk.com/role/StatementsofNetAssetsAvailableforBenefits": { "parentTag": "us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://gsk.com/role/StatementsofNetAssetsAvailableforBenefits" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "EBP, Asset", "documentation": "Amount of asset held by employee stock purchase, saving, or similar plan (employee benefit plan (EBP))." } } }, "auth_ref": [ "r56", "r65", "r96", "r146", "r212" ] }, "us-gaap-ebp_EmployeeBenefitPlanAssetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanAssetAbstract", "presentation": [ "http://gsk.com/role/StatementsofNetAssetsAvailableforBenefits" ], "lang": { "en-us": { "role": { "terseLabel": "Assets", "label": "EBP, Asset [Abstract]" } } }, "auth_ref": [] }, "us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentInvestmentExcludingPlanInterestInMasterTrustCurrentValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanAssetHeldForInvestmentInvestmentExcludingPlanInterestInMasterTrustCurrentValue", "crdr": "debit", "presentation": [ "http://gsk.com/role/ScheduleHLine4iScheduleofAssetsHeldatEndofYearDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total Investments", "label": "EBP, Asset Held for Investment, Investment, Excluding Plan Interest in Master Trust, Current Value", "documentation": "Current value of investment, excluding plan interest in master trust, in schedule of asset held for investment of employee stock purchase, saving, or similar plan (employee benefit plan (EBP)). Includes, but is not limited to, derivative, investment measured at net asset value per share as practical expedient, and insurance contract." } } }, "auth_ref": [ "r95", "r163" ] }, "us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentParticipantLoanAfterDeemedDistribution": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanAssetHeldForInvestmentParticipantLoanAfterDeemedDistribution", "crdr": "debit", "presentation": [ "http://gsk.com/role/ScheduleHLine4iScheduleofAssetsHeldatEndofYearDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Participant loans", "label": "EBP, Asset Held for Investment, Participant Loan, after Deemed Distribution", "documentation": "Amount, after deemed distribution, of participant loan in schedule of asset held for investment of employee stock purchase, saving, or similar plan (employee benefit plan (EBP))." } } }, "auth_ref": [ "r95", "r163" ] }, "us-gaap-ebp_EmployeeBenefitPlanBasisOfAccountingPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanBasisOfAccountingPolicyTextBlock", "presentation": [ "http://gsk.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Basis of Presentation", "label": "EBP, Basis of Accounting [Policy Text Block]", "documentation": "Disclosure of accounting policy for basis of accounting used to prepare financial statements of employee stock purchase, saving, or similar plan (employee benefit plan (EBP))." } } }, "auth_ref": [ "r191", "r202" ] }, "us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecrease": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecrease", "crdr": "credit", "calculation": { "http://gsk.com/role/StatementofChangesinNetAssetsAvailableforBenefits": { "parentTag": "us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecrease", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://gsk.com/role/StatementofChangesinNetAssetsAvailableforBenefits" ], "lang": { "en-us": { "role": { "totalLabel": "Total deductions", "label": "EBP, Change in Net Asset Available for Benefit, Decrease", "documentation": "Amount of decrease in net asset available for benefit to participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP))." } } }, "auth_ref": [ "r146", "r156" ] }, "us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseAbstract", "presentation": [ "http://gsk.com/role/StatementofChangesinNetAssetsAvailableforBenefits" ], "lang": { "en-us": { "role": { "terseLabel": "Deductions from net assets attributed to", "label": "EBP, Change in Net Asset Available for Benefit, Decrease [Abstract]" } } }, "auth_ref": [] }, "us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForAdministrativeExpense", "crdr": "credit", "calculation": { "http://gsk.com/role/StatementofChangesinNetAssetsAvailableforBenefits": { "parentTag": "us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecrease", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://gsk.com/role/StatementofChangesinNetAssetsAvailableforBenefits" ], "lang": { "en-us": { "role": { "terseLabel": "Administrative expenses and investment management fees", "label": "EBP, Change in Net Asset Available for Benefit, Decrease from Administrative Expense", "documentation": "Amount of decrease in net asset available for benefit from administrative expense incurred by employee stock purchase, saving, or similar plan (employee benefit plan (EBP))." } } }, "auth_ref": [ "r63", "r97", "r146" ] }, "us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForPaymentToParticipant": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForPaymentToParticipant", "crdr": "credit", "calculation": { "http://gsk.com/role/StatementofChangesinNetAssetsAvailableforBenefits": { "parentTag": "us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecrease", "weight": 1.0, "order": 1.0 }, "http://gsk.com/role/ReconciliationtoForm5500ReconciliationofBenefitPaidDetails": { "parentTag": "us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionPaymentToParticipant", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://gsk.com/role/ReconciliationtoForm5500ReconciliationofBenefitPaidDetails", "http://gsk.com/role/StatementofChangesinNetAssetsAvailableforBenefits" ], "lang": { "en-us": { "role": { "terseLabel": "Benefits paid to participants", "verboseLabel": "Benefits paid to participants per the financial statements", "label": "EBP, Change in Net Asset Available for Benefit, Decrease from Payment to Participant", "documentation": "Amount of decrease in net asset available for benefit from payment of benefit to participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP)), including, but not limited to, withdrawal." } } }, "auth_ref": [ "r62", "r92", "r97", "r106", "r146" ] }, "us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncrease": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncrease", "crdr": "debit", "calculation": { "http://gsk.com/role/StatementofChangesinNetAssetsAvailableforBenefits": { "parentTag": "us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecrease", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://gsk.com/role/StatementofChangesinNetAssetsAvailableforBenefits" ], "lang": { "en-us": { "role": { "totalLabel": "Total additions", "label": "EBP, Change in Net Asset Available for Benefit, Increase", "documentation": "Amount of increase in net asset available for benefit to participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP))." } } }, "auth_ref": [ "r146", "r156" ] }, "us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseAbstract", "presentation": [ "http://gsk.com/role/StatementofChangesinNetAssetsAvailableforBenefits" ], "lang": { "en-us": { "role": { "terseLabel": "Additions to net assets attributed to", "label": "EBP, Change in Net Asset Available for Benefit, Increase [Abstract]" } } }, "auth_ref": [] }, "us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecrease": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecrease", "crdr": "debit", "calculation": { "http://gsk.com/role/ReconciliationtoForm5500ReconciliationofNetIncomeDetails": { "parentTag": "us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetIncomeLoss", "weight": 1.0, "order": 1.0 }, "http://gsk.com/role/StatementofChangesinNetAssetsAvailableforBenefits": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://gsk.com/role/ReconciliationtoForm5500ReconciliationofNetIncomeDetails", "http://gsk.com/role/StatementofChangesinNetAssetsAvailableforBenefits" ], "lang": { "en-us": { "role": { "totalLabel": "Net increase in net assets", "terseLabel": "Net increase in net assets available for benefits per financial statements", "label": "EBP, Change in Net Asset Available for Benefit, Increase (Decrease)", "documentation": "Amount of increase (decrease) in net asset available for benefit to participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP))." } } }, "auth_ref": [ "r1", "r97", "r146", "r205" ] }, "us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForGainLossOnInvestment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForGainLossOnInvestment", "crdr": "debit", "calculation": { "http://gsk.com/role/StatementofChangesinNetAssetsAvailableforBenefits": { "parentTag": "us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForIncomeLossOnInvestment", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://gsk.com/role/StatementofChangesinNetAssetsAvailableforBenefits" ], "lang": { "en-us": { "role": { "terseLabel": "Net appreciation in fair value of investments", "label": "EBP, Change in Net Asset Available for Benefit, Increase (Decrease) from Gain (Loss) on Investment", "documentation": "Amount of increase (decrease) in net asset available for benefit from realized and unrealized gain (loss) on investment held by employee stock purchase, saving, or similar plan (employee benefit plan (EBP))." } } }, "auth_ref": [ "r16", "r59", "r109", "r146" ] }, "us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForIncomeLossOnInvestment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForIncomeLossOnInvestment", "crdr": "debit", "calculation": { "http://gsk.com/role/StatementofChangesinNetAssetsAvailableforBenefits": { "parentTag": "us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncrease", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://gsk.com/role/StatementofChangesinNetAssetsAvailableforBenefits" ], "lang": { "en-us": { "role": { "totalLabel": "Total investment income", "label": "EBP, Change in Net Asset Available for Benefit, Increase (Decrease) from Income (Loss) on Investment", "documentation": "Amount of increase (decrease) in net asset available for benefit from income (loss) on investment held by employee stock purchase, saving, or similar plan (employee benefit plan (EBP)). Includes, but is not limited to, realized and unrealized gain (loss) on investment." } } }, "auth_ref": [ "r146" ] }, "us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForIncomeLossOnInvestmentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForIncomeLossOnInvestmentAbstract", "presentation": [ "http://gsk.com/role/StatementofChangesinNetAssetsAvailableforBenefits" ], "lang": { "en-us": { "role": { "terseLabel": "Investment income", "label": "EBP, Change in Net Asset Available for Benefit, Increase (Decrease) from Income (Loss) on Investment [Abstract]" } } }, "auth_ref": [] }, "us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForContribution": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForContribution", "crdr": "debit", "calculation": { "http://gsk.com/role/StatementofChangesinNetAssetsAvailableforBenefits": { "parentTag": "us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncrease", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://gsk.com/role/DescriptionofthePlanDetails", "http://gsk.com/role/StatementofChangesinNetAssetsAvailableforBenefits" ], "lang": { "en-us": { "role": { "totalLabel": "Total contributions", "terseLabel": "Contributions", "label": "EBP, Change in Net Asset Available for Benefit, Increase from Contribution", "documentation": "Amount of increase in net asset available for benefit from contribution to employee stock purchase, saving, or similar plan (employee benefit plan (EBP))." } } }, "auth_ref": [ "r146", "r156" ] }, "us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForContributionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForContributionAbstract", "presentation": [ "http://gsk.com/role/StatementofChangesinNetAssetsAvailableforBenefits" ], "lang": { "en-us": { "role": { "terseLabel": "Contributions", "label": "EBP, Change in Net Asset Available for Benefit, Increase from Contribution [Abstract]" } } }, "auth_ref": [] }, "us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForDividendIncomeOnInvestment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForDividendIncomeOnInvestment", "crdr": "debit", "calculation": { "http://gsk.com/role/StatementofChangesinNetAssetsAvailableforBenefits": { "parentTag": "us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForIncomeLossOnInvestment", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://gsk.com/role/RelatedPartyandPartyinInterestTransactionsDetails", "http://gsk.com/role/StatementofChangesinNetAssetsAvailableforBenefits" ], "lang": { "en-us": { "role": { "terseLabel": "Dividend income", "label": "EBP, Change in Net Asset Available for Benefit, Increase from Dividend Income on Investment", "documentation": "Amount of increase in net asset available for benefit from dividend income on investment held by employee stock purchase, saving, or similar plan (employee benefit plan (EBP))." } } }, "auth_ref": [ "r85", "r146", "r188", "r208" ] }, "us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForEmployerContributionCash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForEmployerContributionCash", "crdr": "debit", "calculation": { "http://gsk.com/role/StatementofChangesinNetAssetsAvailableforBenefits": { "parentTag": "us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForContribution", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://gsk.com/role/StatementofChangesinNetAssetsAvailableforBenefits" ], "lang": { "en-us": { "role": { "terseLabel": "Employer", "label": "EBP, Change in Net Asset Available for Benefit, Increase from Employer Contribution, Cash", "documentation": "Amount of increase in net asset available for benefit from cash contribution from employer of participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP))." } } }, "auth_ref": [ "r60", "r146" ] }, "us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForInterestIncomeOnInvestment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForInterestIncomeOnInvestment", "crdr": "debit", "calculation": { "http://gsk.com/role/StatementofChangesinNetAssetsAvailableforBenefits": { "parentTag": "us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForIncomeLossOnInvestment", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://gsk.com/role/StatementofChangesinNetAssetsAvailableforBenefits" ], "lang": { "en-us": { "role": { "terseLabel": "Interest income", "label": "EBP, Change in Net Asset Available for Benefit, Increase from Interest Income on Investment", "documentation": "Amount of increase in net asset available for benefit from interest income on investment held by employee stock purchase, saving, or similar plan (employee benefit plan (EBP)). Excludes interest income on note receivable from participant." } } }, "auth_ref": [ "r84", "r146", "r188", "r208" ] }, "us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForParticipantContribution": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForParticipantContribution", "crdr": "debit", "calculation": { "http://gsk.com/role/StatementofChangesinNetAssetsAvailableforBenefits": { "parentTag": "us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForContribution", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://gsk.com/role/StatementofChangesinNetAssetsAvailableforBenefits" ], "lang": { "en-us": { "role": { "terseLabel": "Participant", "label": "EBP, Change in Net Asset Available for Benefit, Increase from Participant Contribution", "documentation": "Amount of increase in net asset available for benefit from contribution by participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP))." } } }, "auth_ref": [ "r61", "r91", "r97", "r106", "r199" ] }, "us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForParticipantContributionRollover": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForParticipantContributionRollover", "crdr": "debit", "calculation": { "http://gsk.com/role/StatementofChangesinNetAssetsAvailableforBenefits": { "parentTag": "us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForContribution", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://gsk.com/role/DescriptionofthePlanDetails", "http://gsk.com/role/StatementofChangesinNetAssetsAvailableforBenefits" ], "lang": { "en-us": { "role": { "terseLabel": "Rollover", "label": "EBP, Change in Net Asset Available for Benefit, Increase from Participant Contribution, Rollover", "documentation": "Amount of increase in net asset available for benefit from contribution transferred from another qualified plan or from individual retirement account of participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP)). Excludes contribution for participant transmitted by employer of participant in EBP." } } }, "auth_ref": [ "r146", "r151", "r152", "r153", "r199", "r200" ] }, "us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanDescriptionOfPlanAbstract", "lang": { "en-us": { "role": { "label": "EBP, Description of Plan and Accounting Change [Abstract]" } } }, "auth_ref": [] }, "us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanDescriptionOfPlanLineItems", "presentation": [ "http://gsk.com/role/DescriptionofthePlan", "http://gsk.com/role/DescriptionofthePlanDetails" ], "lang": { "en-us": { "role": { "terseLabel": "EBP, Description of Plan [Line Items]", "label": "EBP, Description of Plan [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r154" ] }, "us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanDescriptionOfPlanTable", "presentation": [ "http://gsk.com/role/DescriptionofthePlan", "http://gsk.com/role/DescriptionofthePlanDetails" ], "lang": { "en-us": { "role": { "terseLabel": "EBP, Description of Plan [Table]", "label": "EBP, Description of Plan [Table]", "documentation": "Disclosure of information about description of employee stock purchase, saving, or similar plan (employee benefit plan (EBP))." } } }, "auth_ref": [ "r154" ] }, "us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanDescriptionOfPlanTextBlock", "presentation": [ "http://gsk.com/role/DescriptionofthePlan" ], "lang": { "en-us": { "role": { "terseLabel": "Description of the Plan", "label": "EBP, Description of Plan [Text Block]", "documentation": "The entire disclosure for description of employee stock purchase, saving, or similar plan (employee benefit plan (EBP)). Includes, but is not limited to, vesting and allocation provisions and disposition of forfeiture." } } }, "auth_ref": [ "r3", "r4", "r5", "r64", "r146" ] }, "us-gaap-ebp_EmployeeBenefitPlanEmployerCommonStockFundMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanEmployerCommonStockFundMember", "presentation": [ "http://gsk.com/role/RelatedPartyandPartyinInterestTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "GSK Stock Fund", "label": "EBP, Employer, Common Stock Fund [Member]", "documentation": "Fund with common stock issued by employer of participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP))." } } }, "auth_ref": [ "r125", "r185", "r192", "r198", "r206", "r210", "r211" ] }, "us-gaap-ebp_EmployeeBenefitPlanEmployerContributionMatchingPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanEmployerContributionMatchingPercentage", "presentation": [ "http://gsk.com/role/DescriptionofthePlanDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Matching percentage", "label": "EBP, Employer Contribution, Matching Percentage", "documentation": "Percentage of employer matching contribution on eligible participant contribution to employee stock purchase, saving, or similar plan (employee benefit plan (EBP))." } } }, "auth_ref": [ "r146" ] }, "us-gaap-ebp_EmployeeBenefitPlanEmployerContributionParticipantCompensationMatchedPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanEmployerContributionParticipantCompensationMatchedPercentage", "presentation": [ "http://gsk.com/role/DescriptionofthePlanDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Participant compensation matched, percentage", "label": "EBP, Employer Contribution, Participant Compensation Matched, Percentage", "documentation": "Percentage of participant compensation eligible for employer matching contribution for participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP))." } } }, "auth_ref": [ "r146" ] }, "us-gaap-ebp_EmployeeBenefitPlanEmployerContributionReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanEmployerContributionReceivable", "crdr": "debit", "calculation": { "http://gsk.com/role/StatementsofNetAssetsAvailableforBenefits": { "parentTag": "us-gaap-ebp_EmployeeBenefitPlanReceivable", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://gsk.com/role/StatementsofNetAssetsAvailableforBenefits" ], "lang": { "en-us": { "role": { "terseLabel": "Employer contributions", "label": "EBP, Employer Contribution, Receivable", "documentation": "Amount of contribution receivable from employer of participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP))." } } }, "auth_ref": [ "r96", "r98", "r146" ] }, "us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetAssetAvailableForBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanForm5500CaptionNetAssetAvailableForBenefit", "crdr": "debit", "calculation": { "http://gsk.com/role/ReconciliationtoForm5500ReconciliationofNetAssetsAvailableforBenefitDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://gsk.com/role/ReconciliationtoForm5500ReconciliationofNetAssetsAvailableforBenefitDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net assets available for benefits per Form 5500, Schedule H", "label": "EBP, Form 5500 Caption, Net Assets", "documentation": "Amount of net asset available for benefit as reported in Form 5500 caption for employee stock purchase, saving, or similar plan (employee benefit plan (EBP)). Form 5500 is form provided by Department of the Treasury, Internal Revenue Service (IRS); Department of Labor (DOL), Employee Benefit Security Administration (EBSA); and Pension Benefit Guaranty Corporation (PBGC)." } } }, "auth_ref": [ "r146", "r190" ] }, "us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanForm5500CaptionNetIncomeLoss", "crdr": "debit", "calculation": { "http://gsk.com/role/ReconciliationtoForm5500ReconciliationofNetIncomeDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://gsk.com/role/ReconciliationtoForm5500ReconciliationofNetIncomeDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net increase in net assets available for benefits per Form 5500, Schedule H", "label": "EBP, Form 5500 Caption, Net Income (Loss)", "documentation": "Amount of increase (decrease) in net asset available for benefit from net income (loss) as reported in Form 5500 caption for employee stock purchase, saving, or similar plan (employee benefit plan (EBP)). Form 5500 is form provided by Department of the Treasury, Internal Revenue Service (IRS); Department of Labor (DOL), Employee Benefit Security Administration (EBSA); and Pension Benefit Guaranty Corporation (PBGC)." } } }, "auth_ref": [ "r157", "r190" ] }, "us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionPaymentToParticipant": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanForm5500CaptionPaymentToParticipant", "crdr": "credit", "calculation": { "http://gsk.com/role/ReconciliationtoForm5500ReconciliationofBenefitPaidDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://gsk.com/role/ReconciliationtoForm5500ReconciliationofBenefitPaidDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Benefits paid to participants per Form 5500, Schedule H (2e, 2g)", "label": "EBP, Form 5500 Caption, Benefit Payment and Payments to Provide Benefits", "documentation": "Amount of decrease in net asset available for benefit from benefit payment and payment to provide benefit as reported in Form 5500 caption for employee stock purchase, saving, or similar plan (employee benefit plan (EBP)). Includes, but is not limited to, payment to provide benefit directly to participant, direct rollover, and payment to insurance carrier. Form 5500 is form provided by Department of the Treasury, Internal Revenue Service (IRS); Department of Labor (DOL), Employee Benefit Security Administration (EBSA); and Pension Benefit Guaranty Corporation (PBGC)." } } }, "auth_ref": [ "r146", "r190" ] }, "us-gaap-ebp_EmployeeBenefitPlanFullyBenefitResponsiveInvestmentContractAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanFullyBenefitResponsiveInvestmentContractAbstract", "lang": { "en-us": { "role": { "label": "EBP, Fully Benefit-Responsive Investment Contract [Abstract]" } } }, "auth_ref": [] }, "us-gaap-ebp_EmployeeBenefitPlanFullyBenefitResponsiveInvestmentContractLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanFullyBenefitResponsiveInvestmentContractLineItems", "presentation": [ "http://gsk.com/role/RisksandUncertainties", "http://gsk.com/role/RisksandUncertaintiesTables", "http://gsk.com/role/SyntheticGuaranteedInvestmentContracts", "http://gsk.com/role/SyntheticGuaranteedInvestmentContractsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "EBP, Fully Benefit-Responsive Investment Contract [Line Items]", "label": "EBP, Fully Benefit-Responsive Investment Contract [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r101", "r107" ] }, "us-gaap-ebp_EmployeeBenefitPlanFullyBenefitResponsiveInvestmentContractTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanFullyBenefitResponsiveInvestmentContractTable", "presentation": [ "http://gsk.com/role/RisksandUncertainties", "http://gsk.com/role/RisksandUncertaintiesTables", "http://gsk.com/role/SyntheticGuaranteedInvestmentContracts", "http://gsk.com/role/SyntheticGuaranteedInvestmentContractsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "EBP, Fully Benefit-Responsive Investment Contract [Table]", "label": "EBP, Fully Benefit-Responsive Investment Contract [Table]", "documentation": "Disclosure of information about fully benefit-responsive investment contract held by employee stock purchase, saving, or similar plan (employee benefit plan (EBP))." } } }, "auth_ref": [ "r101", "r107", "r146" ] }, "us-gaap-ebp_EmployeeBenefitPlanInvestmentAcquiredExcludingPlanInterestInMasterTrustCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanInvestmentAcquiredExcludingPlanInterestInMasterTrustCost", "crdr": "debit", "presentation": [ "http://gsk.com/role/RelatedPartyandPartyinInterestTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investment acquired", "label": "EBP, Investment Acquired, Excluding Plan Interest in Master Trust, Cost", "documentation": "Cost of investment, excluding plan interest in master trust, acquired by employee stock purchase, saving, or similar plan (employee benefit plan (EBP))." } } }, "auth_ref": [ "r169", "r176", "r182" ] }, "us-gaap-ebp_EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustContractValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustContractValue", "crdr": "debit", "calculation": { "http://gsk.com/role/StatementsofNetAssetsAvailableforBenefits": { "parentTag": "us-gaap-ebp_EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairAndContractValue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://gsk.com/role/StatementsofNetAssetsAvailableforBenefits" ], "lang": { "en-us": { "role": { "terseLabel": "Fully benefit responsive investment contracts at contract value", "label": "EBP, Investment, Excluding Plan Interest in Master Trust, Contract Value", "documentation": "Contract value of investment, excluding plan interest in master trust, held by employee stock purchase, saving, or similar plan (employee benefit plan (EBP)). Includes, but is not limited to, insurance contract meeting fully benefit-responsive investment criteria." } } }, "auth_ref": [ "r70", "r76", "r107", "r146", "r201" ] }, "us-gaap-ebp_EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairAndContractValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairAndContractValue", "crdr": "debit", "calculation": { "http://gsk.com/role/StatementsofNetAssetsAvailableforBenefits": { "parentTag": "us-gaap-ebp_EmployeeBenefitPlanAsset", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://gsk.com/role/StatementsofNetAssetsAvailableforBenefits" ], "lang": { "en-us": { "role": { "totalLabel": "Total investments", "label": "EBP, Investment, Excluding Plan Interest in Master Trust, Fair and Contract Value", "documentation": "Fair and contract value of investment, excluding plan interest in master trust, held by employee stock purchase, saving, or similar plan (employee benefit plan (EBP)). Includes, but is not limited to, derivative, investment measured at net asset value per share as practical expedient, and insurance contract." } } }, "auth_ref": [ "r197" ] }, "us-gaap-ebp_EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue", "crdr": "debit", "calculation": { "http://gsk.com/role/StatementsofNetAssetsAvailableforBenefits": { "parentTag": "us-gaap-ebp_EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairAndContractValue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://gsk.com/role/FairValueMeasurementsFairvaluehierarchyDetails", "http://gsk.com/role/FairValueMeasurementsInvestmentsmeasuredatfairvaluebasedonNAVDetails", "http://gsk.com/role/RisksandUncertaintiesScheduleofinvestmentsDetails", "http://gsk.com/role/StatementsofNetAssetsAvailableforBenefits" ], "lang": { "en-us": { "role": { "terseLabel": "Investments at fair value", "label": "EBP, Investment, Excluding Plan Interest in Master Trust, Fair Value", "documentation": "Fair value of investment, excluding plan interest in master trust, held by employee stock purchase, saving, or similar plan (employee benefit plan (EBP)). Includes, but is not limited to, derivative, investment measured at net asset value per share as practical expedient, and insurance contract not meeting fully-benefit responsive investment criteria." } } }, "auth_ref": [ "r15", "r17", "r18", "r25", "r26", "r28", "r29", "r35", "r36", "r38", "r101", "r119", "r120", "r121", "r122", "r123", "r124", "r125", "r126", "r127", "r128", "r146" ] }, "us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanInvestmentFairValue", "crdr": "debit", "presentation": [ "http://gsk.com/role/RisksandUncertaintiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value of Investment", "label": "EBP, Investment, Fair Value", "documentation": "Fair value of investment held by employee stock purchase, saving, or similar plan (employee benefit plan (EBP)). Includes, but is not limited to, derivative, investment measured at net asset value per share as practical expedient, and insurance contract not meeting fully-benefit responsive investment criteria." } } }, "auth_ref": [ "r15", "r17", "r18", "r25", "r26", "r28", "r29", "r35", "r36", "r38", "r70", "r71", "r72", "r73", "r74", "r75", "r76", "r101", "r108", "r110", "r111", "r112", "r133", "r134", "r136", "r137", "r138", "r139", "r140", "r141", "r147", "r201" ] }, "us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanInvestmentFairValueAndNavAbstract", "lang": { "en-us": { "role": { "label": "EBP, Investment, Fair Value and NAV [Abstract]" } } }, "auth_ref": [] }, "us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanInvestmentFairValueAndNavLineItems", "presentation": [ "http://gsk.com/role/FairValueMeasurements", "http://gsk.com/role/FairValueMeasurementsFairvaluehierarchyDetails", "http://gsk.com/role/FairValueMeasurementsInvestmentsmeasuredatfairvaluebasedonNAVDetails", "http://gsk.com/role/FairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "terseLabel": "EBP, Investment, Fair Value and NAV [Line Items]", "label": "EBP, Investment, Fair Value and NAV [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r30", "r31", "r32", "r35", "r36", "r38", "r39", "r40", "r41", "r42", "r43", "r44", "r68", "r89", "r119", "r120", "r121", "r122", "r123", "r124", "r125", "r126", "r127", "r128" ] }, "us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanInvestmentFairValueAndNavTable", "presentation": [ "http://gsk.com/role/FairValueMeasurements", "http://gsk.com/role/FairValueMeasurementsFairvaluehierarchyDetails", "http://gsk.com/role/FairValueMeasurementsInvestmentsmeasuredatfairvaluebasedonNAVDetails", "http://gsk.com/role/FairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "terseLabel": "EBP, Investment, Fair Value and NAV [Table]", "label": "EBP, Investment, Fair Value and NAV [Table]", "documentation": "Disclosure of information about fair value of investment held by employee stock purchase, saving, or similar plan (employee benefit plan (EBP)), including, but not limited to, fair value measured at net asset value per share as practical expedient (NAV)." } } }, "auth_ref": [ "r29", "r30", "r31", "r32", "r35", "r36", "r38", "r39", "r40", "r41", "r42", "r43", "r44", "r68", "r89", "r104", "r119", "r120", "r121", "r122", "r123", "r124", "r125", "r126", "r127", "r128" ] }, "us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanInvestmentFairValueAndNavTableTextBlock", "presentation": [ "http://gsk.com/role/FairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "terseLabel": "EBP, Investment, Fair Value and NAV", "label": "EBP, Investment, Fair Value and NAV [Table Text Block]", "documentation": "Tabular disclosure of fair value of investment held by employee stock purchase, saving, or similar plan (employee benefit plan (EBP)), including, but not limited to, fair value measured at net asset value per share as practical expedient (NAV)." } } }, "auth_ref": [ "r27", "r34", "r36", "r37", "r45", "r146", "r203", "r204", "r207" ] }, "us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanInvestmentFairValueAndNavTextBlock", "presentation": [ "http://gsk.com/role/FairValueMeasurements" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Measurements", "label": "EBP, Investment, Fair Value and NAV [Text Block]", "documentation": "The entire disclosure for fair value of investment held by employee stock purchase, saving, or similar plan (employee benefit plan (EBP)), including, but not limited to, fair value measured at net asset value per share as practical expedient (NAV)." } } }, "auth_ref": [ "r30", "r32", "r33", "r35", "r36", "r38", "r41", "r42", "r43", "r44", "r68", "r89", "r90", "r101", "r102", "r146", "r149" ] }, "us-gaap-ebp_EmployeeBenefitPlanInvestmentIncomeReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanInvestmentIncomeReceivable", "crdr": "debit", "calculation": { "http://gsk.com/role/StatementsofNetAssetsAvailableforBenefits": { "parentTag": "us-gaap-ebp_EmployeeBenefitPlanReceivable", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://gsk.com/role/StatementsofNetAssetsAvailableforBenefits" ], "lang": { "en-us": { "role": { "terseLabel": "Dividends and interest", "label": "EBP, Investment Income, Receivable", "documentation": "Amount of receivable for income earned but not yet received on investment held by employee stock purchase, saving, or similar plan (employee benefit plan (EBP)). Includes, but is not limited to, dividend and interest receivables." } } }, "auth_ref": [ "r0", "r113", "r115", "r147" ] }, "us-gaap-ebp_EmployeeBenefitPlanInvestmentPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanInvestmentPolicyTextBlock", "presentation": [ "http://gsk.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Investment Valuation and Income Recognition", "label": "EBP, Investment [Policy Text Block]", "documentation": "Disclosure of accounting policy for investment held by employee stock purchase, saving, or similar plan (employee benefit plan (EBP))." } } }, "auth_ref": [ "r100", "r104", "r105", "r146" ] }, "us-gaap-ebp_EmployeeBenefitPlanInvestmentSoldExcludingPlanInterestInMasterTrustSellingPrice": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanInvestmentSoldExcludingPlanInterestInMasterTrustSellingPrice", "crdr": "credit", "presentation": [ "http://gsk.com/role/RelatedPartyandPartyinInterestTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investment sold", "label": "EBP, Investment Sold, Excluding Plan Interest in Master Trust, Selling Price", "documentation": "Amount of selling price for investment, excluding plan interest in master trust, sold by employee stock purchase, saving, or similar plan (employee benefit plan (EBP))." } } }, "auth_ref": [ "r89", "r168", "r169", "r174", "r183" ] }, "us-gaap-ebp_EmployeeBenefitPlanLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanLiability", "crdr": "credit", "calculation": { "http://gsk.com/role/StatementsofNetAssetsAvailableforBenefits": { "parentTag": "us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://gsk.com/role/StatementsofNetAssetsAvailableforBenefits" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "label": "EBP, Liability", "documentation": "Amount of liability of employee stock purchase, saving, or similar plan (employee benefit plan (EBP))." } } }, "auth_ref": [ "r57", "r81", "r96", "r146", "r212" ] }, "us-gaap-ebp_EmployeeBenefitPlanLiabilityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanLiabilityAbstract", "presentation": [ "http://gsk.com/role/StatementsofNetAssetsAvailableforBenefits" ], "lang": { "en-us": { "role": { "terseLabel": "Liabilities", "label": "EBP, Liability [Abstract]" } } }, "auth_ref": [] }, "us-gaap-ebp_EmployeeBenefitPlanLiabilityInvestmentPurchase": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanLiabilityInvestmentPurchase", "crdr": "credit", "calculation": { "http://gsk.com/role/StatementsofNetAssetsAvailableforBenefits": { "parentTag": "us-gaap-ebp_EmployeeBenefitPlanLiability", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://gsk.com/role/StatementsofNetAssetsAvailableforBenefits" ], "lang": { "en-us": { "role": { "terseLabel": "Payables for securities purchased", "label": "EBP, Liability for Investment Purchase", "documentation": "Amount of liability for purchase of investment held by employee stock purchase, saving, or similar plan (employee benefit plan (EBP))." } } }, "auth_ref": [ "r118", "r144", "r147" ] }, "us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanNetAssetAvailableForBenefit", "crdr": "debit", "calculation": { "http://gsk.com/role/ReconciliationtoForm5500ReconciliationofNetAssetsAvailableforBenefitDetails": { "parentTag": "us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetAssetAvailableForBenefit", "weight": 1.0, "order": 1.0 }, "http://gsk.com/role/StatementsofNetAssetsAvailableforBenefits": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://gsk.com/role/ReconciliationtoForm5500ReconciliationofNetAssetsAvailableforBenefitDetails", "http://gsk.com/role/StatementofChangesinNetAssetsAvailableforBenefits", "http://gsk.com/role/StatementsofNetAssetsAvailableforBenefits" ], "lang": { "en-us": { "role": { "totalLabel": "Net assets available for benefits", "periodStartLabel": "Beginning of year", "periodEndLabel": "End of year", "terseLabel": "Net assets available for benefits per the financial statements", "label": "EBP, Net Asset Available for Benefit", "documentation": "Amount of asset less liability available to pay benefit of participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP)), including, but not limited to, aggregation of participants' individual account balances." } } }, "auth_ref": [ "r2", "r58", "r82", "r93", "r94", "r103", "r113", "r146", "r147", "r201" ] }, "us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipant": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanNoteReceivableFromParticipant", "crdr": "debit", "calculation": { "http://gsk.com/role/StatementsofNetAssetsAvailableforBenefits": { "parentTag": "us-gaap-ebp_EmployeeBenefitPlanReceivable", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://gsk.com/role/StatementsofNetAssetsAvailableforBenefits" ], "lang": { "en-us": { "role": { "terseLabel": "Participant loans receivable", "label": "EBP, Note Receivable from Participant", "documentation": "Amount of unpaid principal plus accrued but unpaid interest for loan from participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP))." } } }, "auth_ref": [ "r99", "r146", "r201" ] }, "us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantAccountMaximumBorrowingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanNoteReceivableFromParticipantAccountMaximumBorrowingAmount", "crdr": "debit", "presentation": [ "http://gsk.com/role/DescriptionofthePlanDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum borrowing, amount", "label": "EBP, Note Receivable from Participant, Account, Maximum Borrowing, Amount", "documentation": "Amount of maximum account balance that participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP)) can borrow." } } }, "auth_ref": [ "r146" ] }, "us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantAccountMaximumBorrowingToTotalAccountPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanNoteReceivableFromParticipantAccountMaximumBorrowingToTotalAccountPercentage", "presentation": [ "http://gsk.com/role/DescriptionofthePlanDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum borrowing, to total account, percentage", "label": "EBP, Note Receivable from Participant, Account, Maximum Borrowing, to Total Account, Percentage", "documentation": "Percentage of maximum account balance that participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP)) can borrow to total participant account balance." } } }, "auth_ref": [ "r146" ] }, "us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantAccountMinimumBorrowingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanNoteReceivableFromParticipantAccountMinimumBorrowingAmount", "crdr": "debit", "presentation": [ "http://gsk.com/role/DescriptionofthePlanDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum borrowing, amount", "label": "EBP, Note Receivable from Participant, Account, Minimum Borrowing, Amount", "documentation": "Amount of minimum account balance that participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP)) can borrow." } } }, "auth_ref": [ "r146" ] }, "us-gaap-ebp_EmployeeBenefitPlanOtherRelatedPartyAndPartyInInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanOtherRelatedPartyAndPartyInInterestMember", "presentation": [ "http://gsk.com/role/RelatedPartyandPartyinInterestTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "EBP, Other Related Party and Party-in-Interest", "label": "EBP, Other Related Party and Party-in-Interest [Member]", "documentation": "Related party and party-in-interest to employee stock purchase, saving, or similar plan (employee benefit plan (EBP)), classified as other." } } }, "auth_ref": [ "r193", "r194", "r195", "r196" ] }, "us-gaap-ebp_EmployeeBenefitPlanParticipantContributionReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanParticipantContributionReceivable", "crdr": "debit", "calculation": { "http://gsk.com/role/StatementsofNetAssetsAvailableforBenefits": { "parentTag": "us-gaap-ebp_EmployeeBenefitPlanReceivable", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://gsk.com/role/StatementsofNetAssetsAvailableforBenefits" ], "lang": { "en-us": { "role": { "terseLabel": "Participant contributions", "label": "EBP, Participant Contribution, Receivable", "documentation": "Amount of contribution receivable from participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP))." } } }, "auth_ref": [ "r96", "r98", "r146" ] }, "us-gaap-ebp_EmployeeBenefitPlanParticipantLoanInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanParticipantLoanInterestRate", "presentation": [ "http://gsk.com/role/DescriptionofthePlanDetails", "http://gsk.com/role/ScheduleHLine4iScheduleofAssetsHeldatEndofYearDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest rate", "label": "EBP, Asset Held for Investment, Participant Loan, Interest Rate", "documentation": "Interest rate on participant loan in schedule of asset held for investment of employee stock purchase, saving, or similar plan (employee benefit plan (EBP))." } } }, "auth_ref": [ "r95", "r163" ] }, "us-gaap-ebp_EmployeeBenefitPlanPaymentToParticipantPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanPaymentToParticipantPolicyTextBlock", "presentation": [ "http://gsk.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Benefits Paid to Participants", "label": "EBP, Payment to Participant [Policy Text Block]", "documentation": "Disclosure of accounting policy for payment of benefit to participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP))." } } }, "auth_ref": [ "r146" ] }, "us-gaap-ebp_EmployeeBenefitPlanPlanNumber": { "xbrltype": "threeDigitItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanPlanNumber", "presentation": [ "http://gsk.com/role/ScheduleHLine4iScheduleofAssetsHeldatEndofYearDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Plan number", "label": "EBP, Plan Number", "documentation": "Plan number of employee stock purchase, saving, or similar plan (employee benefit plan (EBP)), in three-digit numeric format." } } }, "auth_ref": [ "r155", "r156", "r158", "r164", "r169", "r170", "r171", "r179", "r201" ] }, "us-gaap-ebp_EmployeeBenefitPlanPlanTerminationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanPlanTerminationTextBlock", "presentation": [ "http://gsk.com/role/PlanTermination" ], "lang": { "en-us": { "role": { "terseLabel": "Plan Termination", "label": "EBP, Plan Termination [Text Block]", "documentation": "The entire disclosure for terminating employee stock purchase, saving, or similar plan (employee benefit plan (EBP)), including, but not limited to, plan under which participant no longer accrues benefit but remains in existence to pay already accrued benefit." } } }, "auth_ref": [ "r114", "r146" ] }, "us-gaap-ebp_EmployeeBenefitPlanReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanReceivable", "crdr": "debit", "calculation": { "http://gsk.com/role/StatementsofNetAssetsAvailableforBenefits": { "parentTag": "us-gaap-ebp_EmployeeBenefitPlanAsset", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://gsk.com/role/StatementsofNetAssetsAvailableforBenefits" ], "lang": { "en-us": { "role": { "totalLabel": "Total receivables", "label": "EBP, Receivable", "documentation": "Amount of receivable of employee stock purchase, saving, or similar plan (employee benefit plan (EBP))." } } }, "auth_ref": [ "r146", "r201" ] }, "us-gaap-ebp_EmployeeBenefitPlanReceivableAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanReceivableAbstract", "presentation": [ "http://gsk.com/role/StatementsofNetAssetsAvailableforBenefits" ], "lang": { "en-us": { "role": { "terseLabel": "Receivables", "label": "EBP, Receivable [Abstract]" } } }, "auth_ref": [] }, "us-gaap-ebp_EmployeeBenefitPlanReceivableInvestmentSale": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanReceivableInvestmentSale", "crdr": "debit", "calculation": { "http://gsk.com/role/StatementsofNetAssetsAvailableforBenefits": { "parentTag": "us-gaap-ebp_EmployeeBenefitPlanReceivable", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://gsk.com/role/StatementsofNetAssetsAvailableforBenefits" ], "lang": { "en-us": { "role": { "terseLabel": "Receivables for securities sold", "label": "EBP, Investment Sale, Receivable", "documentation": "Amount of receivable for sale of investment held by employee stock purchase, saving, or similar plan (employee benefit plan (EBP))." } } }, "auth_ref": [ "r143", "r147" ] }, "us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500Abstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanReconciliationToForm5500Abstract", "lang": { "en-us": { "role": { "label": "EBP, Reconciliation of Financial Statement to Form 5500 [Abstract]" } } }, "auth_ref": [] }, "us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500ChangeInNetAssetAvailableForBenefitDecreaseForDeemedDistributionCurrentPeriod": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanReconciliationToForm5500ChangeInNetAssetAvailableForBenefitDecreaseForDeemedDistributionCurrentPeriod", "crdr": "credit", "calculation": { "http://gsk.com/role/ReconciliationtoForm5500ReconciliationofNetIncomeDetails": { "parentTag": "us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetIncomeLoss", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://gsk.com/role/ReconciliationtoForm5500ReconciliationofNetIncomeDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Current year deemed distributions", "label": "EBP, Reconciliation to Form 5500, Change in Net Asset Available for Benefit, Current Period, Decrease from Deemed Distribution", "documentation": "Amount of decrease in net asset available for benefit from deemed distribution in current period to participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP)) to reconcile change in net asset available for benefit per financial statement to Form 5500 caption. Form 5500 is form provided by Department of the Treasury, Internal Revenue Service (IRS); Department of Labor (DOL), Employee Benefit Security Administration (EBSA); and Pension Benefit Guaranty Corporation (PBGC)." } } }, "auth_ref": [ "r157", "r190" ] }, "us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500ChangeInNetAssetAvailableForBenefitIncreaseForDeemedDistributionPriorPeriod": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanReconciliationToForm5500ChangeInNetAssetAvailableForBenefitIncreaseForDeemedDistributionPriorPeriod", "crdr": "debit", "calculation": { "http://gsk.com/role/ReconciliationtoForm5500ReconciliationofNetIncomeDetails": { "parentTag": "us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetIncomeLoss", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://gsk.com/role/ReconciliationtoForm5500ReconciliationofNetIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prior year deemed distributions", "label": "EBP, Reconciliation to Form 5500, Change in Net Asset Available for Benefit, Prior Period, Increase from Deemed Distribution", "documentation": "Amount of increase in net asset available for benefit from deemed distribution in prior period to participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP)) to reconcile change in net asset available for benefit per financial statement to Form 5500 caption. Form 5500 is form provided by Department of the Treasury, Internal Revenue Service (IRS); Department of Labor (DOL), Employee Benefit Security Administration (EBSA); and Pension Benefit Guaranty Corporation (PBGC)." } } }, "auth_ref": [ "r157", "r190" ] }, "us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500LineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanReconciliationToForm5500LineItems", "presentation": [ "http://gsk.com/role/ReconciliationtoForm5500", "http://gsk.com/role/ReconciliationtoForm5500ReconciliationofBenefitPaidDetails", "http://gsk.com/role/ReconciliationtoForm5500ReconciliationofNetAssetsAvailableforBenefitDetails", "http://gsk.com/role/ReconciliationtoForm5500ReconciliationofNetIncomeDetails", "http://gsk.com/role/ReconciliationtoForm5500Tables" ], "lang": { "en-us": { "role": { "terseLabel": "EBP, Reconciliation of Financial Statement to Form 5500 [Line Items]", "label": "EBP, Reconciliation of Financial Statement to Form 5500 [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r190" ] }, "us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500NetAssetAvailableForBenefitAllocationToWithdrawingParticipantNotYetPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanReconciliationToForm5500NetAssetAvailableForBenefitAllocationToWithdrawingParticipantNotYetPaid", "crdr": "credit", "calculation": { "http://gsk.com/role/ReconciliationtoForm5500ReconciliationofNetAssetsAvailableforBenefitDetails": { "parentTag": "us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetAssetAvailableForBenefit", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://gsk.com/role/ReconciliationtoForm5500ReconciliationofNetAssetsAvailableforBenefitDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Amounts allocated to withdrawing participants", "label": "EBP, Reconciliation to Form 5500, Net Asset Available for Benefit, Allocation to Withdrawing Participant, Not yet Paid", "documentation": "Amount of asset allocated, but not yet paid, to participant electing to withdraw from employee stock purchase, saving, or similar plan (employee benefit plan (EBP)) to reconcile net asset available for benefit per financial statement to Form 5500 caption. Form 5500 is form provided by Department of the Treasury, Internal Revenue Service (IRS); Department of Labor (DOL), Employee Benefit Security Administration (EBSA); and Pension Benefit Guaranty Corporation (PBGC)." } } }, "auth_ref": [ "r146", "r190" ] }, "us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500NetAssetAvailableForBenefitDeemedDistribution": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanReconciliationToForm5500NetAssetAvailableForBenefitDeemedDistribution", "crdr": "credit", "calculation": { "http://gsk.com/role/ReconciliationtoForm5500ReconciliationofNetAssetsAvailableforBenefitDetails": { "parentTag": "us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetAssetAvailableForBenefit", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://gsk.com/role/ReconciliationtoForm5500ReconciliationofNetAssetsAvailableforBenefitDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Deemed distributions adjustment", "label": "EBP, Reconciliation to Form 5500, Net Asset Available for Benefit, Deemed Distribution", "documentation": "Amount of deemed distribution to participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP)) to reconcile net asset available for benefit per financial statement to Form 5500 caption. Form 5500 is form provided by Department of the Treasury, Internal Revenue Service (IRS); Department of Labor (DOL), Employee Benefit Security Administration (EBSA); and Pension Benefit Guaranty Corporation (PBGC)." } } }, "auth_ref": [ "r157", "r190" ] }, "us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500PaymentToParticipantDecreaseForAllocationToWithdrawingParticipantPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanReconciliationToForm5500PaymentToParticipantDecreaseForAllocationToWithdrawingParticipantPaid", "crdr": "debit", "calculation": { "http://gsk.com/role/ReconciliationtoForm5500ReconciliationofNetIncomeDetails": { "parentTag": "us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetIncomeLoss", "weight": 1.0, "order": 3.0 }, "http://gsk.com/role/ReconciliationtoForm5500ReconciliationofBenefitPaidDetails": { "parentTag": "us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionPaymentToParticipant", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://gsk.com/role/ReconciliationtoForm5500ReconciliationofBenefitPaidDetails", "http://gsk.com/role/ReconciliationtoForm5500ReconciliationofNetIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amounts allocated to withdrawing participants in 2024", "negatedTerseLabel": "Amounts allocated to withdrawing participants at December 31, 2024", "label": "EBP, Reconciliation to Form 5500, Payment to Participant, Decrease from Allocation to Withdrawing Participant, Paid", "documentation": "Amount of decrease in benefit payment from amount allocated in prior period, but paid in current period, to participant electing to withdraw from employee stock purchase, saving, or similar plan (employee benefit plan (EBP)) to reconcile benefit payment per financial statement to Form 5500 caption. Form 5500 is form provided by Department of the Treasury, Internal Revenue Service (IRS); Department of Labor (DOL), Employee Benefit Security Administration (EBSA); and Pension Benefit Guaranty Corporation (PBGC)." } } }, "auth_ref": [ "r146", "r190" ] }, "us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500PaymentToParticipantIncreaseForAllocationToWithdrawingParticipantNotYetPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanReconciliationToForm5500PaymentToParticipantIncreaseForAllocationToWithdrawingParticipantNotYetPaid", "crdr": "credit", "calculation": { "http://gsk.com/role/ReconciliationtoForm5500ReconciliationofNetIncomeDetails": { "parentTag": "us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetIncomeLoss", "weight": -1.0, "order": 2.0 }, "http://gsk.com/role/ReconciliationtoForm5500ReconciliationofBenefitPaidDetails": { "parentTag": "us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionPaymentToParticipant", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://gsk.com/role/ReconciliationtoForm5500ReconciliationofBenefitPaidDetails", "http://gsk.com/role/ReconciliationtoForm5500ReconciliationofNetIncomeDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Amounts allocated to withdrawing participants in 2025", "terseLabel": "Amounts allocated to withdrawing participants at December 31, 2025", "label": "EBP, Reconciliation to Form 5500, Payment to Participant, Increase from Allocation to Withdrawing Participant, Not yet Paid", "documentation": "Amount of increase in benefit payment from amount allocated, but not yet paid, in current period to participant electing to withdraw from employee stock purchase, saving, or similar plan (employee benefit plan (EBP)) to reconcile benefit payment per financial statement to Form 5500 caption. Form 5500 is form provided by Department of the Treasury, Internal Revenue Service (IRS); Department of Labor (DOL), Employee Benefit Security Administration (EBSA); and Pension Benefit Guaranty Corporation (PBGC)." } } }, "auth_ref": [ "r146", "r190" ] }, "us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500Table": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanReconciliationToForm5500Table", "presentation": [ "http://gsk.com/role/ReconciliationtoForm5500", "http://gsk.com/role/ReconciliationtoForm5500ReconciliationofBenefitPaidDetails", "http://gsk.com/role/ReconciliationtoForm5500ReconciliationofNetAssetsAvailableforBenefitDetails", "http://gsk.com/role/ReconciliationtoForm5500ReconciliationofNetIncomeDetails", "http://gsk.com/role/ReconciliationtoForm5500Tables" ], "lang": { "en-us": { "role": { "terseLabel": "EBP, Reconciliation of Financial Statement to Form 5500 [Table]", "label": "EBP, Reconciliation of Financial Statement to Form 5500 [Table]", "documentation": "Disclosure of information about reconciliation of financial statement to Form 5500 for employee stock purchase, saving, or similar plan (employee benefit plan (EBP)). Form 5500 is form provided by Department of the Treasury, Internal Revenue Service (IRS); Department of Labor (DOL), Employee Benefit Security Administration (EBSA); and Pension Benefit Guaranty Corporation (PBGC)." } } }, "auth_ref": [ "r190" ] }, "us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500TableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanReconciliationToForm5500TableTextBlock", "presentation": [ "http://gsk.com/role/ReconciliationtoForm5500Tables" ], "lang": { "en-us": { "role": { "terseLabel": "EBP, Reconciliation of Financial Statement to Form 5500", "label": "EBP, Reconciliation of Financial Statement to Form 5500 [Table Text Block]", "documentation": "Tabular disclosure of reconciliation of financial statement to Form 5500 for employee stock purchase, saving, or similar plan (employee benefit plan (EBP)). Form 5500 is form provided by Department of the Treasury, Internal Revenue Service (IRS); Department of Labor (DOL), Employee Benefit Security Administration (EBSA); and Pension Benefit Guaranty Corporation (PBGC)." } } }, "auth_ref": [ "r146" ] }, "us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500TextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanReconciliationToForm5500TextBlock", "presentation": [ "http://gsk.com/role/ReconciliationtoForm5500" ], "lang": { "en-us": { "role": { "terseLabel": "Reconciliation to Form 5500", "label": "EBP, Reconciliation of Financial Statement to Form 5500 [Text Block]", "documentation": "The entire disclosure for reconciliation of financial statement to Form 5500 for employee stock purchase, saving, or similar plan (employee benefit plan (EBP)). Form 5500 is form provided by Department of the Treasury, Internal Revenue Service (IRS); Department of Labor (DOL), Employee Benefit Security Administration (EBSA); and Pension Benefit Guaranty Corporation (PBGC)." } } }, "auth_ref": [ "r67", "r146" ] }, "us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanRelatedPartyAndPartyInInterestAxis", "presentation": [ "http://gsk.com/role/RelatedPartyandPartyinInterestTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "EBP, Related Party and Party-in-Interest [Axis]", "label": "EBP, Related Party and Party-in-Interest [Axis]", "documentation": "Information by related party and party-in-interest to employee stock purchase, saving, or similar plan (employee benefit plan (EBP))." } } }, "auth_ref": [ "r51", "r77", "r78", "r146" ] }, "us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanRelatedPartyAndPartyInInterestDomain", "presentation": [ "http://gsk.com/role/RelatedPartyandPartyinInterestTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "EBP, Related Party and Party-in-Interest [Domain]", "label": "EBP, Related Party and Party-in-Interest [Domain]", "documentation": "Related party and party-in-interest to employee stock purchase, saving, or similar plan (employee benefit plan (EBP))." } } }, "auth_ref": [ "r51", "r77", "r78", "r146" ] }, "us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsAbstract", "lang": { "en-us": { "role": { "label": "EBP, Related Party and Party-in-Interest Transactions [Abstract]" } } }, "auth_ref": [] }, "us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsLineItems", "presentation": [ "http://gsk.com/role/RelatedPartyandPartyinInterestTransactions", "http://gsk.com/role/RelatedPartyandPartyinInterestTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "EBP, Related Party and Party-in-Interest Transactions [Line Items]", "label": "EBP, Related Party and Party-in-Interest Transactions [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r51", "r191", "r202" ] }, "us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsTable", "presentation": [ "http://gsk.com/role/RelatedPartyandPartyinInterestTransactions", "http://gsk.com/role/RelatedPartyandPartyinInterestTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "EBP, Related Party and Party-in-Interest Transactions [Table]", "label": "EBP, Related Party and Party-in-Interest Transactions [Table]", "documentation": "Disclosure of information about related party and party-in-interest transactions with employee stock purchase, saving, or similar plan (employee benefit plan (EBP))." } } }, "auth_ref": [ "r51", "r191", "r202" ] }, "us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsTextBlock", "presentation": [ "http://gsk.com/role/RelatedPartyandPartyinInterestTransactions" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party and Party in Interest Transactions", "label": "EBP, Related Party and Party-in-Interest Transactions [Text Block]", "documentation": "The entire disclosure for related party and party-in-interest transactions with employee stock purchase, saving, or similar plan (employee benefit plan (EBP))." } } }, "auth_ref": [ "r48", "r49", "r50", "r51", "r146" ] }, "us-gaap-ebp_EmployeeBenefitPlanRiskAndUncertaintyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanRiskAndUncertaintyTextBlock", "presentation": [ "http://gsk.com/role/RisksandUncertainties" ], "lang": { "en-us": { "role": { "terseLabel": "Risks and Uncertainties", "label": "EBP, Risk and Uncertainty [Text Block]", "documentation": "The entire disclosure for risk and uncertainty of employee stock purchase, saving, or similar plan (employee benefit plan (EBP)). Includes, but is not limited to, concentration risk." } } }, "auth_ref": [ "r8", "r12", "r14", "r46", "r47", "r146" ] }, "us-gaap-ebp_EmployeeBenefitPlanScheduleOfAllocationIncomeAndChangeInPlanEquityLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanScheduleOfAllocationIncomeAndChangeInPlanEquityLineItems", "presentation": [ "http://gsk.com/role/PlanTermination" ], "lang": { "en-us": { "role": { "terseLabel": "EBP, Schedule of Allocation, Income and Change in Plan Equity [Line Items]", "label": "EBP, Schedule of Allocation, Income and Change in Plan Equity [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r97" ] }, "us-gaap-ebp_EmployeeBenefitPlanScheduleOfAllocationIncomeAndChangeInPlanEquityTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanScheduleOfAllocationIncomeAndChangeInPlanEquityTable", "presentation": [ "http://gsk.com/role/PlanTermination" ], "lang": { "en-us": { "role": { "terseLabel": "EBP, Schedule of Allocation, Income and Change in Plan Equity [Table]", "label": "EBP, Schedule of Allocation, Income and Change in Plan Equity [Table]", "documentation": "Disclosure of information about allocation of income and change in plan equity in employee stock purchase, saving, or similar plan (employee benefit plan (EBP))." } } }, "auth_ref": [ "r97" ] }, "us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentAbstract", "lang": { "en-us": { "role": { "label": "EBP, Schedule of Asset Held for Investment [Abstract]" } } }, "auth_ref": [] }, "us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems", "presentation": [ "http://gsk.com/role/ScheduleHLine4iScheduleofAssetsHeldatEndofYear", "http://gsk.com/role/ScheduleHLine4iScheduleofAssetsHeldatEndofYearDetails" ], "lang": { "en-us": { "role": { "terseLabel": "EBP, Schedule of Asset Held for Investment [Line Items]", "label": "EBP, Schedule of Asset Held for Investment [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r95", "r160", "r161", "r162", "r163" ] }, "us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTable", "presentation": [ "http://gsk.com/role/ScheduleHLine4iScheduleofAssetsHeldatEndofYear", "http://gsk.com/role/ScheduleHLine4iScheduleofAssetsHeldatEndofYearDetails" ], "lang": { "en-us": { "role": { "terseLabel": "EBP, Schedule of Asset Held for Investment [Table]", "label": "EBP, Schedule of Asset Held for Investment [Table]", "documentation": "Disclosure of information about schedule of asset held for investment of employee stock purchase, saving, or similar plan (employee benefit plan (EBP))." } } }, "auth_ref": [ "r95", "r160", "r161", "r162", "r163" ] }, "us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTableTextBlock", "presentation": [ "http://gsk.com/role/ScheduleHLine4iScheduleofAssetsHeldatEndofYear" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule H, Line 4i - Schedule of Assets (Held at End of Year)", "label": "EBP, Schedule of Asset Held for Investment [Table Text Block]", "documentation": "Tabular disclosure of schedule of asset held for investment of employee stock purchase, saving, or similar plan (employee benefit plan (EBP))." } } }, "auth_ref": [ "r155", "r159" ] }, "us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitAbstract", "lang": { "en-us": { "role": { "label": "EBP, Statement of Change in Net Asset Available for Benefit [Abstract]" } } }, "auth_ref": [] }, "us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitLineItems", "presentation": [ "http://gsk.com/role/StatementofChangesinNetAssetsAvailableforBenefits" ], "lang": { "en-us": { "role": { "terseLabel": "EBP, Statement of Change in Net Asset Available for Benefit [Line Items]", "label": "EBP, Statement of Change in Net Asset Available for Benefit [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r86", "r87", "r88", "r103" ] }, "us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitTable", "presentation": [ "http://gsk.com/role/StatementofChangesinNetAssetsAvailableforBenefits" ], "lang": { "en-us": { "role": { "terseLabel": "EBP, Statement of Change in Net Asset Available for Benefit [Table]", "label": "EBP, Statement of Change in Net Asset Available for Benefit [Table]", "documentation": "Presentation of information about change in net asset available for benefit for employee stock purchase, saving, or similar plan (employee benefit plan (EBP))." } } }, "auth_ref": [ "r86", "r87", "r88", "r103" ] }, "us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitAbstract", "lang": { "en-us": { "role": { "label": "EBP, Statement of Net Asset Available for Benefit [Abstract]" } } }, "auth_ref": [] }, "us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitLineItems", "presentation": [ "http://gsk.com/role/StatementsofNetAssetsAvailableforBenefits" ], "lang": { "en-us": { "role": { "terseLabel": "EBP, Statement of Net Asset Available for Benefit [Line Items]", "label": "EBP, Statement of Net Asset Available for Benefit [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r71", "r72", "r73", "r74", "r75", "r76", "r77", "r78", "r79", "r80", "r101", "r103", "r119", "r120", "r121", "r122", "r123", "r124", "r125", "r126", "r127", "r128" ] }, "us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitTable", "presentation": [ "http://gsk.com/role/StatementsofNetAssetsAvailableforBenefits" ], "lang": { "en-us": { "role": { "terseLabel": "EBP, Statement of Net Asset Available for Benefit [Table]", "label": "EBP, Statement of Net Asset Available for Benefit [Table]", "documentation": "Presentation of information about net asset available for benefit for employee stock purchase, saving, or similar plan (employee benefit plan (EBP))." } } }, "auth_ref": [ "r71", "r72", "r73", "r74", "r75", "r76", "r77", "r78", "r79", "r80", "r101", "r103", "r119", "r120", "r121", "r122", "r123", "r124", "r125", "r126", "r127" ] }, "us-gaap-ebp_EmployeeBenefitPlanSubsequentEventTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanSubsequentEventTextBlock", "presentation": [ "http://gsk.com/role/SubsequentEvents" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Events", "label": "EBP, Subsequent Event [Text Block]", "documentation": "The entire disclosure for subsequent event in financial statement of employee stock purchase, saving, or similar plan (employee benefit plan (EBP))." } } }, "auth_ref": [ "r53", "r55", "r191", "r202" ] }, "us-gaap-ebp_EmployeeBenefitPlanSummaryOfAccountingPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanSummaryOfAccountingPolicyTextBlock", "presentation": [ "http://gsk.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncements" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Significant Accounting Policies and Recent Accounting Pronouncements", "label": "EBP, Summary of Accounting Policy [Text Block]", "documentation": "The entire disclosure for summary of accounting policy used to prepare financial statement of employee stock purchase, saving, or similar plan (employee benefit plan (EBP))." } } }, "auth_ref": [ "r3", "r4", "r146" ] }, "us-gaap-ebp_EmployeeBenefitPlanSyntheticInvestmentContractMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanSyntheticInvestmentContractMember", "presentation": [ "http://gsk.com/role/ScheduleHLine4iScheduleofAssetsHeldatEndofYearDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Synthetic GICs", "label": "EBP, Synthetic Investment Contract [Member]", "documentation": "Contract, held by employee stock purchase, saving, or similar plan (employee benefit plan (EBP)), simulating performance of traditional guaranteed investment contract through use of financial instrument." } } }, "auth_ref": [ "r130", "r131", "r132", "r142", "r146" ] }, "us-gaap-ebp_EmployeeBenefitPlanTaxStatusAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanTaxStatusAbstract", "lang": { "en-us": { "role": { "label": "EBP, Tax Status [Abstract]" } } }, "auth_ref": [] }, "us-gaap-ebp_EmployeeBenefitPlanTaxStatusLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanTaxStatusLineItems", "presentation": [ "http://gsk.com/role/TaxStatus" ], "lang": { "en-us": { "role": { "terseLabel": "EBP, Tax Status [Line Items]", "label": "EBP, Tax Status [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r189" ] }, "us-gaap-ebp_EmployeeBenefitPlanTaxStatusTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanTaxStatusTable", "presentation": [ "http://gsk.com/role/TaxStatus" ], "lang": { "en-us": { "role": { "terseLabel": "EBP, Tax Status [Table]", "label": "EBP, Tax Status [Table]", "documentation": "Disclosure of information about tax status of employee stock purchase, saving, or similar plan (employee benefit plan (EBP)). Includes, but is not limited to, information concerning whether tax ruling or determination letter was obtained and principal assumption on which plan relied in not making provision for federal income tax." } } }, "auth_ref": [ "r189" ] }, "us-gaap-ebp_EmployeeBenefitPlanTaxStatusTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanTaxStatusTextBlock", "presentation": [ "http://gsk.com/role/TaxStatus" ], "lang": { "en-us": { "role": { "terseLabel": "Tax Status", "label": "EBP, Tax Status [Text Block]", "documentation": "The entire disclosure for tax status of employee stock purchase, saving, or similar plan (employee benefit plan (EBP)). Includes, but is not limited to, information concerning whether tax ruling or determination letter was obtained and principal assumption on which plan relied in not making provision for federal income tax." } } }, "auth_ref": [ "r66", "r69", "r146" ] }, "us-gaap-ebp_EmployeeBenefitPlanUseOfEstimatePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap-ebp/2025", "localname": "EmployeeBenefitPlanUseOfEstimatePolicyTextBlock", "presentation": [ "http://gsk.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Use of Estimates", "label": "EBP, Use of Estimate [Policy Text Block]", "documentation": "Disclosure of accounting policy for use of estimate in preparation of financial statement of employee stock purchase, saving, or similar plan (employee benefit plan (EBP))." } } }, "auth_ref": [ "r6", "r7", "r9", "r10", "r11", "r13", "r146" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityCentralIndexKey", "presentation": [ "http://gsk.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r148" ] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityDomain", "presentation": [ "http://gsk.com/role/Cover", "http://gsk.com/role/DescriptionofthePlan", "http://gsk.com/role/DescriptionofthePlanDetails", "http://gsk.com/role/FairValueMeasurements", "http://gsk.com/role/FairValueMeasurementsFairvaluehierarchyDetails", "http://gsk.com/role/FairValueMeasurementsInvestmentsmeasuredatfairvaluebasedonNAVDetails", "http://gsk.com/role/FairValueMeasurementsTables", "http://gsk.com/role/PlanTermination", "http://gsk.com/role/ReconciliationtoForm5500", "http://gsk.com/role/ReconciliationtoForm5500ReconciliationofBenefitPaidDetails", "http://gsk.com/role/ReconciliationtoForm5500ReconciliationofNetAssetsAvailableforBenefitDetails", "http://gsk.com/role/ReconciliationtoForm5500ReconciliationofNetIncomeDetails", "http://gsk.com/role/ReconciliationtoForm5500Tables", "http://gsk.com/role/RelatedPartyandPartyinInterestTransactions", "http://gsk.com/role/RelatedPartyandPartyinInterestTransactionsDetails", "http://gsk.com/role/RisksandUncertainties", "http://gsk.com/role/RisksandUncertaintiesNarrativeDetails", "http://gsk.com/role/RisksandUncertaintiesScheduleofinvestmentsDetails", "http://gsk.com/role/RisksandUncertaintiesTables", "http://gsk.com/role/ScheduleHLine4iScheduleofAssetsHeldatEndofYear", "http://gsk.com/role/ScheduleHLine4iScheduleofAssetsHeldatEndofYearDetails", "http://gsk.com/role/StatementofChangesinNetAssetsAvailableforBenefits", "http://gsk.com/role/StatementsofNetAssetsAvailableforBenefits", "http://gsk.com/role/SubsequentEvents", "http://gsk.com/role/SubsequentEventsDetails", "http://gsk.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncements", "http://gsk.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsPolicies", "http://gsk.com/role/SyntheticGuaranteedInvestmentContracts", "http://gsk.com/role/SyntheticGuaranteedInvestmentContractsDetails", "http://gsk.com/role/TaxStatus" ], "lang": { "en-us": { "role": { "terseLabel": "Entity [Domain]", "label": "Entity [Domain]", "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityRegistrantName", "presentation": [ "http://gsk.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r148" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://gsk.com/role/ScheduleHLine4iScheduleofAssetsHeldatEndofYearDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r148" ] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://gsk.com/role/FairValueMeasurementsFairvaluehierarchyDetails", "http://gsk.com/role/FairValueMeasurementsInvestmentsmeasuredatfairvaluebasedonNAVDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Hierarchy and NAV [Axis]", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "auth_ref": [ "r29", "r30", "r31", "r32", "r35", "r36", "r38", "r102", "r146" ] }, "us-gaap_FairValueInputsLevel12And3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueInputsLevel12And3Member", "presentation": [ "http://gsk.com/role/FairValueMeasurementsFairvaluehierarchyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total", "label": "Fair Value, Inputs, Level 1, Level 2, and Level 3 [Member]" } } }, "auth_ref": [ "r186", "r204", "r206" ] }, "us-gaap_FairValueInputsLevel1Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueInputsLevel1Member", "presentation": [ "http://gsk.com/role/FairValueMeasurementsFairvaluehierarchyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level 1", "label": "Fair Value, Inputs, Level 1 [Member]" } } }, "auth_ref": [ "r29", "r35", "r129", "r146" ] }, "us-gaap_FairValueInputsLevel2Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueInputsLevel2Member", "presentation": [ "http://gsk.com/role/FairValueMeasurementsFairvaluehierarchyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level 2", "label": "Fair Value, Inputs, Level 2 [Member]" } } }, "auth_ref": [ "r29", "r30", "r35", "r129", "r146" ] }, "us-gaap_FairValueInputsLevel3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueInputsLevel3Member", "presentation": [ "http://gsk.com/role/FairValueMeasurementsFairvaluehierarchyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level 3", "label": "Fair Value, Inputs, Level 3 [Member]" } } }, "auth_ref": [ "r29", "r30", "r31", "r32", "r35", "r36", "r129", "r146" ] }, "us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueMeasuredAtNetAssetValuePerShareMember", "presentation": [ "http://gsk.com/role/FairValueMeasurementsFairvaluehierarchyDetails", "http://gsk.com/role/FairValueMeasurementsInvestmentsmeasuredatfairvaluebasedonNAVDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net asset value", "label": "Fair Value Measured at Net Asset Value Per Share [Member]" } } }, "auth_ref": [ "r38", "r129" ] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://gsk.com/role/FairValueMeasurementsFairvaluehierarchyDetails", "http://gsk.com/role/FairValueMeasurementsInvestmentsmeasuredatfairvaluebasedonNAVDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Hierarchy and NAV [Domain]", "label": "Fair Value Hierarchy and NAV [Domain]" } } }, "auth_ref": [ "r29", "r30", "r31", "r32", "r35", "r36", "r38", "r102", "r146" ] }, "us-gaap_InvestmentIdentifierAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "InvestmentIdentifierAxis", "presentation": [ "http://gsk.com/role/RisksandUncertaintiesNarrativeDetails", "http://gsk.com/role/RisksandUncertaintiesScheduleofinvestmentsDetails", "http://gsk.com/role/ScheduleHLine4iScheduleofAssetsHeldatEndofYearDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investment, Identifier [Axis]", "label": "Investment, Identifier [Axis]" } } }, "auth_ref": [ "r95", "r160", "r161", "r162", "r163", "r165", "r166", "r167", "r168", "r169", "r170", "r172", "r173", "r174", "r175", "r176", "r177", "r178", "r180", "r181", "r182", "r183", "r184" ] }, "us-gaap_InvestmentTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "InvestmentTypeAxis", "presentation": [ "http://gsk.com/role/DescriptionofthePlanDetails", "http://gsk.com/role/FairValueMeasurementsFairvaluehierarchyDetails", "http://gsk.com/role/FairValueMeasurementsInvestmentsmeasuredatfairvaluebasedonNAVDetails", "http://gsk.com/role/RelatedPartyandPartyinInterestTransactionsDetails", "http://gsk.com/role/ScheduleHLine4iScheduleofAssetsHeldatEndofYearDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investment Type [Axis]", "label": "Investment Type [Axis]" } } }, "auth_ref": [ "r15", "r16", "r17", "r18", "r19", "r20", "r21", "r22", "r23", "r24", "r25", "r28", "r29", "r30", "r31", "r32", "r35", "r36", "r38", "r39", "r40", "r41", "r42", "r43", "r44", "r68", "r71", "r72", "r73", "r74", "r75", "r76", "r83", "r86", "r87", "r88", "r89", "r95", "r101", "r107", "r110", "r112", "r116", "r119", "r120", "r121", "r122", "r123", "r124", "r125", "r126", "r127", "r128", "r133", "r134", "r135", "r136", "r137", "r138", "r139", "r140", "r141", "r146", "r147", "r163", "r185", "r201" ] }, "us-gaap_InvestmentTypeCategorizationMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "InvestmentTypeCategorizationMember", "presentation": [ "http://gsk.com/role/DescriptionofthePlanDetails", "http://gsk.com/role/FairValueMeasurementsFairvaluehierarchyDetails", "http://gsk.com/role/FairValueMeasurementsInvestmentsmeasuredatfairvaluebasedonNAVDetails", "http://gsk.com/role/RelatedPartyandPartyinInterestTransactionsDetails", "http://gsk.com/role/ScheduleHLine4iScheduleofAssetsHeldatEndofYearDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investments [Domain]", "label": "Investments [Domain]" } } }, "auth_ref": [ "r15", "r16", "r17", "r18", "r19", "r20", "r21", "r22", "r23", "r24", "r25", "r28", "r29", "r30", "r31", "r32", "r35", "r36", "r38", "r39", "r40", "r41", "r42", "r43", "r44", "r68", "r71", "r72", "r73", "r74", "r75", "r76", "r83", "r86", "r87", "r88", "r89", "r95", "r101", "r107", "r110", "r112", "r116", "r119", "r120", "r121", "r122", "r123", "r124", "r125", "r126", "r127", "r128", "r133", "r134", "r135", "r136", "r137", "r138", "r139", "r140", "r141", "r146", "r147", "r163", "r185", "r201" ] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "LegalEntityAxis", "presentation": [ "http://gsk.com/role/Cover", "http://gsk.com/role/DescriptionofthePlan", "http://gsk.com/role/DescriptionofthePlanDetails", "http://gsk.com/role/FairValueMeasurements", "http://gsk.com/role/FairValueMeasurementsFairvaluehierarchyDetails", "http://gsk.com/role/FairValueMeasurementsInvestmentsmeasuredatfairvaluebasedonNAVDetails", "http://gsk.com/role/FairValueMeasurementsTables", "http://gsk.com/role/PlanTermination", "http://gsk.com/role/ReconciliationtoForm5500", "http://gsk.com/role/ReconciliationtoForm5500ReconciliationofBenefitPaidDetails", "http://gsk.com/role/ReconciliationtoForm5500ReconciliationofNetAssetsAvailableforBenefitDetails", "http://gsk.com/role/ReconciliationtoForm5500ReconciliationofNetIncomeDetails", "http://gsk.com/role/ReconciliationtoForm5500Tables", "http://gsk.com/role/RelatedPartyandPartyinInterestTransactions", "http://gsk.com/role/RelatedPartyandPartyinInterestTransactionsDetails", "http://gsk.com/role/RisksandUncertainties", "http://gsk.com/role/RisksandUncertaintiesNarrativeDetails", "http://gsk.com/role/RisksandUncertaintiesScheduleofinvestmentsDetails", "http://gsk.com/role/RisksandUncertaintiesTables", "http://gsk.com/role/ScheduleHLine4iScheduleofAssetsHeldatEndofYear", "http://gsk.com/role/ScheduleHLine4iScheduleofAssetsHeldatEndofYearDetails", "http://gsk.com/role/StatementofChangesinNetAssetsAvailableforBenefits", "http://gsk.com/role/StatementsofNetAssetsAvailableforBenefits", "http://gsk.com/role/SubsequentEvents", "http://gsk.com/role/SubsequentEventsDetails", "http://gsk.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncements", "http://gsk.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsPolicies", "http://gsk.com/role/SyntheticGuaranteedInvestmentContracts", "http://gsk.com/role/SyntheticGuaranteedInvestmentContractsDetails", "http://gsk.com/role/TaxStatus" ], "lang": { "en-us": { "role": { "terseLabel": "Legal Entity [Axis]", "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "MaximumMember", "presentation": [ "http://gsk.com/role/DescriptionofthePlanDetails", "http://gsk.com/role/ScheduleHLine4iScheduleofAssetsHeldatEndofYearDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum", "label": "Maximum [Member]" } } }, "auth_ref": [ "r32", "r146", "r155", "r163" ] }, "gsk_MetWestTotalReturnBondFundCITClassCMember": { "xbrltype": "domainItemType", "nsuri": "http://gsk.com/20260617", "localname": "MetWestTotalReturnBondFundCITClassCMember", "presentation": [ "http://gsk.com/role/FairValueMeasurementsInvestmentsmeasuredatfairvaluebasedonNAVDetails" ], "lang": { "en-us": { "role": { "terseLabel": "MetWest Total Return Bond Fund (CIT) Class C", "label": "MetWest Total Return Bond Fund (CIT) Class C [Member]", "documentation": "MetWest Total Return Bond Fund (CIT) Class C" } } }, "auth_ref": [] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "MinimumMember", "presentation": [ "http://gsk.com/role/DescriptionofthePlanDetails", "http://gsk.com/role/ScheduleHLine4iScheduleofAssetsHeldatEndofYearDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum", "label": "Minimum [Member]" } } }, "auth_ref": [ "r32", "r146", "r155", "r163" ] }, "us-gaap_MoneyMarketFundsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "MoneyMarketFundsMember", "presentation": [ "http://gsk.com/role/FairValueMeasurementsFairvaluehierarchyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Money market fund", "label": "Money Market Funds [Member]" } } }, "auth_ref": [ "r155", "r203", "r206", "r209" ] }, "gsk_MutualFundAndMoneyMarketFundMember": { "xbrltype": "domainItemType", "nsuri": "http://gsk.com/20260617", "localname": "MutualFundAndMoneyMarketFundMember", "presentation": [ "http://gsk.com/role/ScheduleHLine4iScheduleofAssetsHeldatEndofYearDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Mutual fund and Money market fund", "label": "Mutual Fund And Money Market Fund [Member]", "documentation": "Mutual Fund And Money Market Fund" } } }, "auth_ref": [] }, "us-gaap_MutualFundMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "MutualFundMember", "presentation": [ "http://gsk.com/role/FairValueMeasurementsFairvaluehierarchyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Mutual funds", "label": "Mutual Fund [Member]" } } }, "auth_ref": [ "r119", "r130", "r133", "r142", "r146", "r147" ] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "RangeAxis", "presentation": [ "http://gsk.com/role/DescriptionofthePlanDetails", "http://gsk.com/role/ScheduleHLine4iScheduleofAssetsHeldatEndofYearDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Axis]", "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [ "r32", "r146", "r155", "r163" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "RangeMember", "presentation": [ "http://gsk.com/role/DescriptionofthePlanDetails", "http://gsk.com/role/ScheduleHLine4iScheduleofAssetsHeldatEndofYearDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Domain]", "label": "Statistical Measurement [Domain]" } } }, "auth_ref": [ "r32", "r146", "r155", "r163" ] }, "gsk_StableValueFundMember": { "xbrltype": "domainItemType", "nsuri": "http://gsk.com/20260617", "localname": "StableValueFundMember", "presentation": [ "http://gsk.com/role/RelatedPartyandPartyinInterestTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stable Value Fund", "label": "Stable Value Fund [Member]", "documentation": "Stable Value Fund" } } }, "auth_ref": [] }, "gsk_StateStreetGlobalAdvisorFundsMember": { "xbrltype": "domainItemType", "nsuri": "http://gsk.com/20260617", "localname": "StateStreetGlobalAdvisorFundsMember", "presentation": [ "http://gsk.com/role/FairValueMeasurementsInvestmentsmeasuredatfairvaluebasedonNAVDetails" ], "lang": { "en-us": { "role": { "terseLabel": "State Street Global Advisors Funds", "label": "State Street Global Advisor Funds [Member]", "documentation": "State Street Global Advisor Funds" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SubsequentEventMember", "presentation": [ "http://gsk.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event", "label": "Subsequent Event [Member]" } } }, "auth_ref": [ "r52" ] }, "us-gaap_SubsequentEventTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SubsequentEventTypeAxis", "presentation": [ "http://gsk.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event Type [Axis]", "label": "Subsequent Event Type [Axis]" } } }, "auth_ref": [ "r52" ] }, "us-gaap_SubsequentEventTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SubsequentEventTypeDomain", "presentation": [ "http://gsk.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event Type [Domain]", "label": "Subsequent Event Type [Domain]" } } }, "auth_ref": [ "r52" ] }, "gsk_SyntheticGuaranteedInvestmentContractsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://gsk.com/20260617", "localname": "SyntheticGuaranteedInvestmentContractsTextBlock", "presentation": [ "http://gsk.com/role/SyntheticGuaranteedInvestmentContracts" ], "lang": { "en-us": { "role": { "terseLabel": "Synthetic Guaranteed Investment Contracts", "label": "Synthetic Guaranteed Investment Contracts [Text Block]", "documentation": "Synthetic Guaranteed Investment Contracts" } } }, "auth_ref": [] }, "gsk_VanguardRetirementSavingsTrustIVMember": { "xbrltype": "domainItemType", "nsuri": "http://gsk.com/20260617", "localname": "VanguardRetirementSavingsTrustIVMember", "presentation": [ "http://gsk.com/role/DescriptionofthePlanDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vanguard Retirement Savings Trust IV", "label": "Vanguard Retirement Savings Trust IV [Member]", "documentation": "Vanguard Retirement Savings Trust IV" } } }, "auth_ref": [] }, "gsk_VanguardTargetRetirementTrustSelectMember": { "xbrltype": "domainItemType", "nsuri": "http://gsk.com/20260617", "localname": "VanguardTargetRetirementTrustSelectMember", "presentation": [ "http://gsk.com/role/FairValueMeasurementsInvestmentsmeasuredatfairvaluebasedonNAVDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vanguard Target Retirement Trust Select", "label": "Vanguard Target Retirement Trust Select [Member]", "documentation": "Vanguard Target Retirement Trust Select" } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6A-03(4))", "SubTopic": "205", "Topic": "962", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1" }, "r1": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r2": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 11.M.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-5" }, "r4": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SAB Topic 11.M)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-6" }, "r5": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r6": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r7": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r8": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r9": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11" }, "r10": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11" }, "r11": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12" }, "r12": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-2A" }, "r13": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4" }, "r14": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-6" }, "r15": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A" }, "r16": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A" }, "r17": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B" }, "r18": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B" }, "r19": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4K", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4K" }, "r20": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4K", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4K" }, "r21": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4K", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4K" }, "r22": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4K", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4K" }, "r23": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4K", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4K" }, "r24": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4K", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4K" }, "r25": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4K", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4K" }, "r26": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-7A" }, "r27": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r28": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r29": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r30": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r31": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r32": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r33": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r34": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r35": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r36": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r37": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r38": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r39": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r40": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r41": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r42": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r43": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r44": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r45": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-8" }, "r46": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-20" }, "r47": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21" }, "r48": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r49": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r50": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r51": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r52": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2" }, "r53": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2" }, "r54": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2" }, "r55": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-3" }, "r56": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477063/962-205-45-2" }, "r57": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477063/962-205-45-2" }, "r58": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477063/962-205-45-2" }, "r59": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477063/962-205-45-7" }, "r60": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477063/962-205-45-7" }, "r61": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477063/962-205-45-7" }, "r62": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477063/962-205-45-7" }, "r63": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477063/962-205-45-7" }, "r64": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478416/962-205-50-1" }, "r65": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478416/962-205-50-1" }, "r66": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478416/962-205-50-1" }, "r67": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478416/962-205-50-1" }, "r68": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6A-02(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1" }, "r69": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6A-02(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1" }, "r70": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6A-02(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1" }, "r71": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6A-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1" }, "r72": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6A-03(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1" }, "r73": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6A-03(2)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1" }, "r74": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6A-03(2)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1" }, "r75": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6A-03(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1" }, "r76": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6A-03(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1" }, "r77": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6A-03(6)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1" }, "r78": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6A-03(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1" }, "r79": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6A-03(7)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1" }, "r80": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6A-03(7)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1" }, "r81": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6A-03(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1" }, "r82": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6A-03(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1" }, "r83": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6A-04(1)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1" }, "r84": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6A-04(1)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1" }, "r85": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6A-04(1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1" }, "r86": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6A-04(2)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1" }, "r87": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6A-04(2)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1" }, "r88": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6A-04(2)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1" }, "r89": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6A-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1" }, "r90": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6A-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1" }, "r91": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6A-04(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1" }, "r92": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6A-04(5)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1" }, "r93": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6A-04(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1" }, "r94": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6A-04(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1" }, "r95": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6A-05(a)(Schedule I))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1" }, "r96": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6A-05(a)(Schedule II))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1" }, "r97": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6A-05(a)(Schedule III))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1" }, "r98": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478642/962-310-45-1" }, "r99": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478642/962-310-45-2" }, "r100": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "325", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478844/962-325-35-1B" }, "r101": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "325", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477509/962-325-45-5" }, "r102": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "325", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477509/962-325-45-6" }, "r103": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "325", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477509/962-325-45-8" }, "r104": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "325", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-1" }, "r105": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "325", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-2A" }, "r106": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "325", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-2B" }, "r107": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "325", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-3" }, "r108": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "325", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-5" }, "r109": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "325", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-7" }, "r110": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "325", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-8A" }, "r111": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "325", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-8A" }, "r112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "325", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-8B" }, "r113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479750/962-40-25-1" }, "r114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "962", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479684/962-40-50-1" }, "r115": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8C", "Subparagraph": "(e)", "SubTopic": "325", "Topic": "962", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-8C" }, "r116": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4L", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4L" }, "r117": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r118": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477063/962-205-45-4" }, "r119": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "962", "SubTopic": "325", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477509/962-325-45-5" }, "r120": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "962", "SubTopic": "325", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477509/962-325-45-5" }, "r121": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "962", "SubTopic": "325", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477509/962-325-45-5" }, "r122": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "962", "SubTopic": "325", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477509/962-325-45-5" }, "r123": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "962", "SubTopic": "325", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477509/962-325-45-5" }, "r124": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "962", "SubTopic": "325", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477509/962-325-45-5" }, "r125": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "962", "SubTopic": "325", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477509/962-325-45-5" }, "r126": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "962", "SubTopic": "325", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477509/962-325-45-5" }, "r127": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "962", "SubTopic": "325", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477509/962-325-45-5" }, "r128": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "962", "SubTopic": "325", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(k)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477509/962-325-45-5" }, "r129": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "962", "SubTopic": "325", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477509/962-325-45-6" }, "r130": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "962", "SubTopic": "325", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-1" }, "r131": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "962", "SubTopic": "325", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-3" }, "r132": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "962", "SubTopic": "325", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-8A" }, "r133": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "962", "SubTopic": "325", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-8A" }, "r134": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "962", "SubTopic": "325", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-8A" }, "r135": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "962", "SubTopic": "325", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-8A" }, "r136": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "962", "SubTopic": "325", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-8A" }, "r137": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "962", "SubTopic": "325", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8A", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-8A" }, "r138": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "962", "SubTopic": "325", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8A", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-8A" }, "r139": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "962", "SubTopic": "325", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8A", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-8A" }, "r140": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "962", "SubTopic": "325", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8A", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-8A" }, "r141": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "962", "SubTopic": "325", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8A", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-8A" }, "r142": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "962", "SubTopic": "325", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-8B" }, "r143": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "962", "SubTopic": "325", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-8C" }, "r144": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "962", "SubTopic": "325", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-8C" }, "r145": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "962", "SubTopic": "325", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8C", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-8C" }, "r146": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "962", "SubTopic": "325", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478873/962-325-55-17" }, "r147": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "962", "SubTopic": "325", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478873/962-325-55-18" }, "r148": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r149": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-23" }, "r150": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-3" }, "r151": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477063/962-205-45-7" }, "r152": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6A-05(a)(Schedule III))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1" }, "r153": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "962", "SubTopic": "325", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-2B" }, "r154": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "SubTopic": "205", "Topic": "962", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478416/962-205-50-1" }, "r155": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6A-05(a)(Schedule I))", "SubTopic": "205", "Topic": "962", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1" }, "r156": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6A-05(a)(Schedule III))", "SubTopic": "205", "Topic": "962", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1" }, "r157": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Employee Retirement Income Security Act of 1974", "Number": "2520", "Section": "103", "Subsection": "1", "Paragraph": "b", "Subparagraph": "(3)", "Publisher": "DOL-EBSA" }, "r158": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Employee Retirement Income Security Act of 1974", "Number": "2520", "Section": "103", "Subsection": "10", "Paragraph": "b", "Subparagraph": "(1)", "Publisher": "DOL-EBSA" }, "r159": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Employee Retirement Income Security Act of 1974", "Number": "2520", "Section": "103", "Subsection": "10", "Paragraph": "b", "Subparagraph": "(1)(i)", "Publisher": "DOL-EBSA" }, "r160": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Employee Retirement Income Security Act of 1974", "Number": "2520", "Section": "103", "Subsection": "10", "Paragraph": "b", "Subparagraph": "(1)(i)(A)", "Publisher": "DOL-EBSA" }, "r161": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Employee Retirement Income Security Act of 1974", "Number": "2520", "Section": "103", "Subsection": "10", "Paragraph": "b", "Subparagraph": "(1)(i)(B)", "Publisher": "DOL-EBSA" }, "r162": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Employee Retirement Income Security Act of 1974", "Number": "2520", "Section": "103", "Subsection": "10", "Paragraph": "b", "Subparagraph": "(1)(i)(C)", "Publisher": "DOL-EBSA" }, "r163": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Employee Retirement Income Security Act of 1974", "Number": "2520", "Section": "103", "Subsection": "10", "Paragraph": "b", "Subparagraph": "(1)(i)(D)", "Publisher": "DOL-EBSA" }, "r164": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Employee Retirement Income Security Act of 1974", "Number": "2520", "Section": "103", "Subsection": "10", "Paragraph": "b", "Subparagraph": "(2)", "Publisher": "DOL-EBSA" }, "r165": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Employee Retirement Income Security Act of 1974", "Number": "2520", "Section": "103", "Subsection": "10", "Paragraph": "b", "Subparagraph": "(2)(i)(A)", "Publisher": "DOL-EBSA" }, "r166": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Employee Retirement Income Security Act of 1974", "Number": "2520", "Section": "103", "Subsection": "10", "Paragraph": "b", "Subparagraph": "(2)(i)(B)", "Publisher": "DOL-EBSA" }, "r167": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Employee Retirement Income Security Act of 1974", "Number": "2520", "Section": "103", "Subsection": "10", "Paragraph": "b", "Subparagraph": "(2)(i)(C)", "Publisher": "DOL-EBSA" }, "r168": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Employee Retirement Income Security Act of 1974", "Number": "2520", "Section": "103", "Subsection": "10", "Paragraph": "b", "Subparagraph": "(2)(i)(D)", "Publisher": "DOL-EBSA" }, "r169": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Employee Retirement Income Security Act of 1974", "Number": "2520", "Section": "103", "Subsection": "10", "Paragraph": "b", "Subparagraph": "(3)", "Publisher": "DOL-EBSA" }, "r170": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Employee Retirement Income Security Act of 1974", "Number": "2520", "Section": "103", "Subsection": "10", "Paragraph": "b", "Subparagraph": "(4)", "Publisher": "DOL-EBSA" }, "r171": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Employee Retirement Income Security Act of 1974", "Number": "2520", "Section": "103", "Subsection": "6", "Paragraph": "d", "Subparagraph": "(1)", "Publisher": "DOL-EBSA" }, "r172": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Employee Retirement Income Security Act of 1974", "Number": "2520", "Section": "103", "Subsection": "6", "Paragraph": "d", "Subparagraph": "(1)(i)", "Publisher": "DOL-EBSA" }, "r173": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Employee Retirement Income Security Act of 1974", "Number": "2520", "Section": "103", "Subsection": "6", "Paragraph": "d", "Subparagraph": "(1)(ii)", "Publisher": "DOL-EBSA" }, "r174": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Employee Retirement Income Security Act of 1974", "Number": "2520", "Section": "103", "Subsection": "6", "Paragraph": "d", "Subparagraph": "(1)(iii)", "Publisher": "DOL-EBSA" }, "r175": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Employee Retirement Income Security Act of 1974", "Number": "2520", "Section": "103", "Subsection": "6", "Paragraph": "d", "Subparagraph": "(1)(iv)", "Publisher": "DOL-EBSA" }, "r176": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Employee Retirement Income Security Act of 1974", "Number": "2520", "Section": "103", "Subsection": "6", "Paragraph": "d", "Subparagraph": "(1)(v)", "Publisher": "DOL-EBSA" }, "r177": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Employee Retirement Income Security Act of 1974", "Number": "2520", "Section": "103", "Subsection": "6", "Paragraph": "d", "Subparagraph": "(1)(vi)", "Publisher": "DOL-EBSA" }, "r178": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Employee Retirement Income Security Act of 1974", "Number": "2520", "Section": "103", "Subsection": "6", "Paragraph": "d", "Subparagraph": "(1)(vii)", "Publisher": "DOL-EBSA" }, "r179": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Employee Retirement Income Security Act of 1974", "Number": "2520", "Section": "103", "Subsection": "6", "Paragraph": "d", "Subparagraph": "(2)", "Publisher": "DOL-EBSA" }, "r180": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Employee Retirement Income Security Act of 1974", "Number": "2520", "Section": "103", "Subsection": "6", "Paragraph": "d", "Subparagraph": "(2)(i)", "Publisher": "DOL-EBSA" }, "r181": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Employee Retirement Income Security Act of 1974", "Number": "2520", "Section": "103", "Subsection": "6", "Paragraph": "d", "Subparagraph": "(2)(ii)", "Publisher": "DOL-EBSA" }, "r182": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Employee Retirement Income Security Act of 1974", "Number": "2520", "Section": "103", "Subsection": "6", "Paragraph": "d", "Subparagraph": "(2)(iii)", "Publisher": "DOL-EBSA" }, "r183": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Employee Retirement Income Security Act of 1974", "Number": "2520", "Section": "103", "Subsection": "6", "Paragraph": "d", "Subparagraph": "(2)(iv)", "Publisher": "DOL-EBSA" }, "r184": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Employee Retirement Income Security Act of 1974", "Number": "2520", "Section": "103", "Subsection": "6", "Paragraph": "d", "Subparagraph": "(2)(v)", "Publisher": "DOL-EBSA" }, "r185": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r186": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r187": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477063/962-205-45-4" }, "r188": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477063/962-205-45-7" }, "r189": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478416/962-205-50-1" }, "r190": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478416/962-205-50-1" }, "r191": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6A-02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1" }, "r192": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6A-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1" }, "r193": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6A-03(6)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1" }, "r194": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6A-03(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1" }, "r195": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6A-03(7)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1" }, "r196": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6A-03(7)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1" }, "r197": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6A-03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1" }, "r198": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6A-04(2)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1" }, "r199": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6A-04(4)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1" }, "r200": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6A-04(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1" }, "r201": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "962", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6A-05(a)(Schedule II))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1" }, "r202": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "962", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479143/962-235-S50-1" }, "r203": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "962", "SubTopic": "325", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477509/962-325-45-5" }, "r204": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "962", "SubTopic": "325", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477509/962-325-45-6" }, "r205": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "962", "SubTopic": "325", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477509/962-325-45-8" }, "r206": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "962", "SubTopic": "325", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-1" }, "r207": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "962", "SubTopic": "325", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-3" }, "r208": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "962", "SubTopic": "325", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-7" }, "r209": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "962", "SubTopic": "325", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-8A" }, "r210": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "962", "SubTopic": "325", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8A", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-8A" }, "r211": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "962", "SubTopic": "325", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-8B" }, "r212": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "962", "SubTopic": "325", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-8C" } } }